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ABSTRACT
Tinnitus is a phantom sensation of sound in the absence of acoustic stimulus and can be
induced by ototoxic drugs such as sodium salicylate (SS). Tinnitus is likely related to
hyperactivity in central auditory structures. In the central nervous system, activity is dependent
on excitatory/inhibitory neurotransmission. Gamma-aminobutyric acid (GABA) is a major
inhibitory neurotransmitter. It can activate the type-B GABAergic receptor (GABAB receptor),
which can control the level of excitation/inhibition through regulating the release of
neurotransmitters and lowering the cell membrane potential. I hypothesized that SS affects
hearing by changing the level and distribution of the GABAB receptor in central auditory
structures. My results from immunohistochemical and western blotting experiments revealed that
SS reduced the level of GABAB receptors in all major auditory structures. The reduction was
observed in both neuronal cell bodies regions and areas containing axonal and dendritic fibers of
neurons.
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1 Introduction
1.1 Audition
Audition or hearing is the ability of an organism to sense sound. It is one of the five basic
senses and is important for an organism's biological fitness. Hearing is involved in many
behaviours such as prey catching, predator avoidance, mating, and social communication.
Hearing impairment can have detrimental consequences on an organism's survival (Capranica,
1965). In vertebrates including human, hearing is dependent on the auditory system, which can
be divided into the peripheral and the central auditory system (Pickles, 2012).
1.2 Peripheral auditory system
The peripheral auditory system consists of the outer, middle, and inner ear. The outer ear
contains the external ear, also known as pinna, and the ear canal. The middle ear includes the
three oscicles, i.e., the malleus, incus, and stapes. The inner ear includes the cochlea, a spiral
shaped structure. The outer and the middle ears are separated by the tympanic membrane, also
called the eardrum. The middle and inner ears are separated by the oval window of cochlea
(Silverthorn, 2007). Sound waves are transmitted by the pinna to the ear canal where they hit the
tympanic membrane, causing the membrane to vibrate. The vibrations of the tympanic
membrane are amplified by the three oscicles and transferred via the oval window to the Organ
of Corti which is the sensory portion of the cochlea.
A cochlear duct divides the cochlea into three fluid-filled compartments called scalae
vestibuli, scalae tympani, and scalae media. Scalae vestibuli and tympani contain a fluid known
as perilymph. This fluid has a high concentration of Na+ ions and a low concentration of K+ ions
(Johnstone and Sellick, 1972). Scalae media contains endolymph which has a high concentration
1

of K+ ions and a low concentration of Na+ ions. A thin sheet of connective tissue, called the
basilar membrane, prevents the endolymph and perilymph from mixing (Bosher and Warren,
1968).
The Organ of Corti is a sensory epithelium that sits upon the basilar membrane. It is
composed of two types of sensory cells: inner hair cells (IHC) and outer hair cells (OHC). OHCs
are able to change their length in response to cell membrane depolarization/hyperpolarization,
and this property is referred to as electromotility (Bronwell, 1990). OHCs contact another
membrane called the tectorial membrane which overlays the hair cells. IHCs and OHCs contain
stereocilia at their tips or free ends. The stereocilia of hair cells are connected through tip-links.
Sound vibrations cause the basilar membrane and the tectorial membrane to move, which in turn
moves the hair cells. This movement displaces the stereocilia, causing mechanosensitive cation
channels located near the tips of stereocilia to open, resulting in the influx of K+ ions from the
endolymph into a hair cell and depolarization of the cells (Hudspeth, 1982). Thus mechanical
sound vibrations are converted into electrical potentials, which travel via the cochlear nerve to
the central auditory system (Silverthorn, 2007).
1.3 Central auditory system (CAS)
In mammals including humans, the central auditory system is composed of six major
neural structures including the cochlear nucleus (CN), superior olivary complex (SOC), nucleus
of lateral lemniscus (NLL), inferior colliculus (IC), medial geniculate nucleus (MG or MGN),
and the auditory cortex (AC) (See Figure 1). CN, SOC and NLL make up the auditory brainstem,
whereas IC makes up the midbrain. MG and AC constitute the auditory forebrain. The six major
auditory structures form a hierarchy with the CN at the bottom receiving inputs from the inner
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ear while the AC is at the top. The six central auditory structures and their subdivisions can be
seen in Figure 1.
1.3.1 Neural connections in CAS
Projections in the CAS can be defined as ascending or descending. Ascending projections
refer to projections from lower structures i.e. structures located near the sensory organ, to higher
structures i.e. structures located near the cereberal cortex (Figure 2a). Descending projections
refer to projections from higher structures to lower structures (Figure 2b). Ascending projections
connect CN to SOC, NLL, and IC (Schofield and Coomes, 2005). SOC sends ascending
projections to NLL (Grothe and Koch, 2011), and NLL send projections to IC (Zhao and Wu,
2001). The IC sends ascending projections to MG on both sides of the brain (Malmierca and
Merchan, 2005). MG sends ascending projections exclusively to the ipsilateral AC (Winer and
Schreiner, 2005).
The most important descending projections include those from the AC to the MG and the
IC. The IC also sends descending projections to the periolivary medial olivocochlear cells which
innervate the OHCs. Thus, a pathway from the AC to the sensory OHCs is formed (Faye-lund,
1986; Caicedo and Herbert, 1993; Vetter et al., 1993, Saldana, 1993). It is thought that the
descending projections from the AC to the MG modulate the processing of auditory neural
signals carried by ascending projections to this thalamic structure (Winer and Larue, 1987; Roger
and Arnault, 1989; Arnault and Roger, 1990, Shi and Cassel, 1997). Descending projections also
modulate processing in the IC (Faye-Lund, 1985; Coleman and Clerici, 1987; Games and Winer,
1988; Roger and Arnault, 1989), the SOC (Feliciano et al., 1995), and the CN (Feliciano et al.,
1995; Weedman et al., 1996a, 1996b).

3

Figure 1: Schematic representation of coronal sections of the rat brain containing central
auditory structures. Left: diagrams of a rat brain with the black bar indicating the location of its
respective coronal slice. Right: Coronal sections containing central auditory structures in
ascending order going from the bottom to top slice. The first 2 slices contain SOC, CN and its
three subdivisions: DCN, PVCN, and AVCN. The third slice contains NLL and IC which is
divided into its three subdivisions: ICd, ICx, and ICc. The fourth slice contains the three
subdivisions of the MG: MGd, MGv, and MGm. The top slice contains the three subdivisions of
the AC: AU1, AUD, and AUV.
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Figure 2. Diagrams of a human brain (left) and a rat brain (right) showing projections between
auditory structures. A: Major ascending projections between auditory structures from cochlea to
the auditory cortex. Intrinsic and commissural projections are not shown for the purpose of
clarity. B: Major descending projections between central auditory structures.
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There are also intrinsic projections, i.e., projections confined into an individual nucleus,
and commissural projections, i.e., projections crossing the midline of the brain and connecting
the structures on both sides (mouse: Gonzalez-Hernandez et al., 1986; rat: Saldana and Merchan,
1992).
1.3.2 Cochlear nucleus (CN)
The CN is located in the hindbrain and is the first neural structure along the ascending
auditory pathway. It receives direct projections from the spiral ganglion cells in the peripheral
auditory system. CN sends projections to the contralateral SOC, IC, NLL, and MG. CN also
receives descending projections from the AC, IC, SOC, and ventral NLL (Schofield and
Coomes, 2005). CN can be divided into two major subdivisions: the dorsal CN (DCN) and the
ventral CN (VCN). The VCN can be further subdivided into anterior VCN (AVCN) and
posterior VCN (PVCN). These subdivisions can be seen in Figure 1.
VCN
VCN is divided into its posterior and anterior subdivision by the cochlear root nerve.
AVCN receives input from the ascending branch of the cochlear root nerve, whereas PVCN
receives input from the descending branch. Cells in the VCN also receive descending inputs
from the DCN and AC. Cells in PVCN receive a large number of afferents from auditory nerve
fibers (ANF) (McGinley and Oertel, 2006), and send projections to the contralateral NLL, the
dorsal region of ipsilateral SOC (Winer and Schreiner, 2005), and the ventral region of the
contralateral SOC (Warr, 1982). Cells in the AVCN project to the ipsilateral DCN, contralateral
and ipsilateral ventral SOC, ventral IC, and contralateral CN (Merchan et al., 1988). The
innervation of VCN by ANFs is in a tonotopic manner i.e., ANF fibres with lower frequencies
6

innervate the ventral region of VCN, while fibres with high frequencies innervate the dorsal
region of VCN (Manis, 1989; Zhang and Oertel, 1994).
Cells in PVCN fire strongly at the onset of a stimulus (McGinley and Oertel, 2006). They
also respond to the transient component of an ongoing stimulus, and are specialized to detect
temporal fluctuations in complex sounds (Cao and Oertel, 2010). Other cells in PVCN encode
complex sounds in a noisy background, and convey fluctuations in ongoing stimuli (Cao and
Oertel, 2010).
Cells in the AVCN fire whenever ANFs fire, and are able to send precise information
about the temporal properties of acoustic stimuli to the SOC. This information is used by the
SOC in sound localization (Young et al., 1988a).
DCN
The DCN can be divided into four layers and a granule cell domain (GCD). The most
superficial layer, called molecular layer, contains granule cells and small interneurons (Oertel
and Young, 2004). The second layer contains pyramidal cells, which are the major cell type of
DCN. These pyramidal cells receive projections from VCN (Mugnaini et al., 1980a, 1980b), and
send projections to the contralateral IC and the medial division of MG (Schofield and Coomes.
2005). The third and fourth layers, also called the deep layers, contain giant and vertical cells.
Neurons in these layers are contacted by axons of auditory nerve fibers. There is a tonotopic
organization in the DCN. While the lateral and ventral part of the structure is innervated by
ANFs with low frequencies, the dorsal and medial part of DCN is innervated by fibers with high
frequencies (Manis, 1989; Zhang and Oertel, 1994). Thus cells in DCN form isofrequency
sheets, with similar frequency neurons grouping together (Wickesberg and Oertel, 1988). Deep
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layer neurons also receive local innervations from interneurons in the neighbouring superficial
layers, and send projections to the contralateral IC and the MG (Osen et al., 1990).
The GCD is continuous with the first layer of DCN, and is made up of small cells. These
small cells receive ascending projections from VCN and the cochlear nerve (Mugnaini et al.,
1980a, 1980b). The cells in the GCD project to the pyramidal cells in the superficial layers of
DCN, the IC, medial MG, and SOC (Malmierca et al., 2002).
DCN is involved in many complex functions. It is affected by somatosensory inputs and
may help suppress sounds generated by movements or from self-vocalization (Kanold et al.,
2011; Keohler et al., 2011).
1.3.3 Superior Olivary Complex (SOC)
Like the CN, the SOC is also located in the hindbrain. This structure is made up of a
group of small subnuclei including: lateral nucleus of the trapezoidal body (LNTB), the ventral
nucleus of trapezoidal body (VNTB), the medial nucleus of the trapezoidal body (MNTB), the
lateral superior olivary nucleus (LSO), the medial superior olivary nucleus (MSO), and the
superior paraolivary nucleus (SPN). SOC receives projections from the CN, and ipsilateral IC. It
sends projections to the CN, NLL, and IC. SOC plays a role in sound localization (van Adel and
Kelly, 1998), and has also been shown to play a role in inhibiting responses to echoes of sounds
(Malmierca and Merchan, 2005). In spite of the fact that the SOC is an important structure in
central auditory processing, it wasn’t a part of my thesis research as existing results indicate that
this structure does not play an important role in the generation of tinnitus and it has a relatively
low level of the type-B gamma-aminobutyric acid receptor (GABAB receptor) (see section
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1.4.2.2.2). The level of the GABAB receptor and the effect of a tinnitus inducer sodium salicylate
on the level and distribution of the receptor was the focus of the present study.
1.3.4 Nucleus of the Lateral Lemniscus (NLL)
The NLL is a fibrous structure located beneath the IC (Figure 1). It can be divided into
two subdivisions: the dorsal NLL (DNLL) and the ventral NLL (VNLL). VNLL receives inputs
driven by the contralateral ear, and is involved in detecting temporal features of auditory stimuli
(Aitkin et al., 1970). DNLL receives inputs driven by both ears, and is thought to play an
important role in sound localization (Aitkin et al., 1970; Bruggae et al., 1970; Bajo et al., 1998).
In spite of the fact that the NLL is an important structure in central auditory processing, it wasn’t
a part of my thesis research due to the low level of the GABAB receptor and the lack of evidence
showing the involvement of this structure in the generation of tinnitus.
1.3.5 Inferior Colliculus (IC)
The IC is a midbrain structure and is a major auditory processing centre. It receives input
from all the brainstem structures and higher structures, and is the primary source of input to the
MG, which in turn projects to the AC. The IC can be divided into three subdivisions: dorsal
cortex of the inferior colliculus (ICd), central nucleus of the inferior colliculus (ICc) and the
external cortex of the inferior colliculus (ICx) (Figure 1). These subdivisions differ in their
cytoarchitecture, neural connections, and functions. ICc is considered an auditory nucleus, and is
also referred to as the "lemniscal" part of the auditory midbrain because it receives heavy inputs
from the nucleus of lateral lemniscus. ICx and ICd are called "non-lemniscal" or "extralemniscal" nuclei. They form a multisensory auditory pathway and surround the specific auditory
pathway formed by ICc (Morest, 1964a).
9

The ICc
The ICc primarily receives inputs from the ipsilateral VNLL and MSO, contralateral CN,
and ipsilateral and contralateral DNLL and LSO. Inputs from MSO and LSO are sent to the
ventral part of the ICc, whereas inputs from CN and DNLL end up in the dorsal region of the ICc
(Malmierca et al., 1999a; 1999b). ICc also receives inputs from the ipsilateral and contralateral
ICx and ICd (Winer, 2005). There are some inputs to the ICc from higher structures, such as
weak projections from the AC (Schofield, 2009). ICc projects strongly to the ventral region of
the MG on both sides of the brain, and sends weak projections to the medial and dorsal regions
of the MG. It also sends some projections to the contralateral IC (Malmierca and Merchan,
2005).
Neurons in the ICc are classified into “flat” and “less flat” categories based on the shape
of their dendritic fields (Malmierca et al., 1993). Afferent lemniscal fibers and neurons with
flattened dendritic fields in the ICc form "fibrodendritic laminae" (Morest, 1964a). Less flat
neurons populate the space between laminae. These fibrodendritic laminae are thought to be
responsible for processing sounds with different frequencies, with those in the dorsal region
responsible for low frequencies and those in the ventral region responsible for high frequencies.
Thus the fibrodendritic laminae form a structural basis of a tonotopic map. Physiological studies
have shown differences in the best frequency for different laminae, supporting that each lamina
covers a small range of frequencies so that all frequencies may be represented (Schreiner and
Langner, 1997).
Physiological studies have also shown that cells in ICc possess directional selectivity.
Inputs driven by the contralateral ear generate higher/greater responses than inputs driven by the
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ipsilateral ear (Kuwada et al., 2011). Because IC receives projections from higher and lower
auditory structures, it plays an important role in auditory processing.
The ICx
The ICx is located on the lateral side of the IC and can be divided into three layers. It
receives the majority of its inputs from the ipsilateral MG, neighbouring ICc and ICd, and
ipsilateral and contralateral AC (Malmierca et al., 1999a; 1999b). It also receives weak
projections from the NLL. ICx also receives somatosensory input from the trigeminal nuclei. It
projects to the medial and dorsal regions of the ipsilateral and contralateral MG (Faye-Lund and
Osen, 1985; Huffman and Henson, 1990).
Neurons in ICx respond to binaural input i.e. input from both ears, and have been shown
to habituate rapidly. These neurons are excited by auditory stimuli and inhibited by
somatosensory stimuli (Aitkin et al., 1978). The exact function of ICx has not been established
but researchers believe that this structure might be an integrative area for auditory and
somatosensory inputs (Jain and Shore, 2006).
The ICd
The ICd can be divided into four layers. Main sources of input to this structure arise from
the ipsilateral and contralateral AC (Bajo et a., 2007). It also receives inputs from the ipsilateral
ICx and ICc, the contralateral IC, DNLL, SPN, and CN. ICd projects to the dorsal region of the
MG and ICc (Malmierca and Merchan, 2005). The function of this subdivision has not been
established, though it has been shown to play a part in sensory systems other than auditory
system (Malmierca and Merchan, 2005).

11

Neurons in the ICd respond to both monoaural and binaural stimuli and habituate rapidly
(Aitkin et al., 1975). These neurons show a strong response at the onset of stimuli, and to
changes in stimuli, suggesting that ICd might be involved in detecting novel sounds (Lumani
and Zhang, 2010).
1.3.6 Medial Geniculate Nucleus (MG)
The MG is a thalamic structure, and is the last major structure before the AC in the
ascending auditory pathway. It receives projections from the IC and sends ipsilateral projections
to the AC. It also receives heavy inputs from the AC. MG can be divided into three subdivisions:
dorsal division of the medial geniculate nucleus (MGd), medial division of the medial geniculate
nucleus (MGm), and ventral division of the medial geniculate nucleus (MGv) (Figure 1).
The MGv
MGv is part of the "lemniscal" pathway and is considered a specific auditory relay centre.
It receives inputs from the ipsilateral IC, and weak projections from the contralateral ICc
(Gonzalez-Hernandez et al, 1991). It also receives descending inputs from the AC (Malmierca
and Merchan, 2005). MGv is a major source of input to the AC in the ascending pathway, and
has major targets in the ipsilateral AC (Winer and Schreiner, 2005). MGv is known to be mainly
involved in auditory processing, whereas MGm and MGd are known to play a role in integration
of inputs from auditory and other sensory systems (Bordi and LeDoux, 1994).
MGv has a laminar structure, with the laminae running parallel to the isofrequency
planes. These isofrequency regions form a tonotopic organization, with the dorsal region of MGv
responsible for low frequencies and the ventral region responsible for high frequencies (Cetas et
al., 2003). Physiological studies have shown that the best frequency changes between the planes,
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suggesting that patches of neurons might form functional groups, each representing a range of
frequencies (Cetas et al., 2003). Neurons in MGv respond to binaural stimuli. Behavioural
studies have shown that this structure does not play a major role in sound localization (Kelly and
Judge, 1985).
The MGm
This is the smallest of the three subdivisions of MG, and is composed of a thin layer in
the medial part of the MG. This subdivision receives ascending inputs from a wide range of
auditory structures, including the ICx, CN, SOC, and VNLL (LeDoux et al., 1987). MGm also
receives descending inputs from the AC and reticular thalamic nucleus (Winer, 2005). Besides
auditory inputs, MGm receives somatosensory and visual inputs (Malmierca et al., 2002). MGm
projects to the ICd, ICx, and the AC (LeDoux et al., 1987; Winer, 2005). It also projects to nonauditory areas including the somatosensory cortex (Spreafico et al., 1981), and the amygdala
(Otterson and Ben-Ari, 1979; Otterson, 1981; LeDoux, 1985b, 1987).
MGm is not tonotopically organized. However, the ventral region of MGm contains
higher frequency neurons. Because this subdivision projects to auditory and somatosensory
regions, it might respond to both types of sensory stimuli (Bordi and LeDoux, 1994b). Its
projections to the amygdala suggest that MGm is involved in processing the emotional
significance of auditory stimuli (LeDoux et al., 1984, 1985b).
The MGd
The MGd receives ascending projections primarily from the non-lemniscal parts of the IC
i.e. the ICd, and ICx. It receives descending projections from the AC (Winer, 2005). MGd also
receives projections from the somatosensory system (Winer, 1985). As MGd sends projections to
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the ICx, a feedback loop may exist between the two structures (Winer, 1992). The main target of
MGd projections is the non-primary auditory cortex i.e. secondary auditory cortical areas
(Malmiera and Merchan, 2004).
MGd is not tonotopically organized and its neurons do not respond strongly to acoustic
stimuli. These neurons have been shown to prefer complex sounds over pure tone stimuli,
suggesting that this subdivision might be involved in discriminating sound patterns (Bordi and
LeDoux, 1994a, 1994b).
1.3.7 Auditory Cortex (AC)
The AC is part of the temporal cortex, and is found on the dorsolateral surface of the
brain. It plays an important role in auditory sensation, perception, and cognition (Gaese and
Ostwald, 1995). The AC in the rat can be subdivided in two ways. The first way is based on
thalamocortical inputs to the structures as well as physiological responses. In this way the AC is
subdivided into three regions; a central core which is called AU1 or Te1, and surrounding belt
regions located dorsally and ventrally, called Te2 and Te3 (Figure 1). Te1 or AU1 is considered
to be the primary auditory cortex (Games and Winer, 1987; Roger and Arnault, 1989; Herbert et
al., 1991; Saldana et al., 1996) whereas Te2 and Te3 are considered to be secondary auditory
cortices (Arnault and Roger, 1990). The AC can also be divided into six layers based on neuronal
architecture. These layers are labelled layer I to VI, and are anatomically and physiologically
distinct from each other.
Te1(AU1)
Te1 is connected with MGv in a tonotopic manner. It also receives some projections from
MGd and MGm (Roger and Arnault, 1989), and projects to Te2 and Te3 (Romanski and
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LeDoux, 1993b). Studies involving ablation of Te1 have shown that it is not involved in sound
localization (Kelly, 1980). However, it is important for recognition of complex acoustic signals
(Gaese and Ostwald, 1995).
Te2 and Te3
Te2 is connected to MGd and MGm, whereas Te3 is only connected to Mgm (Arnault
and Roger, 1990; Winer et al., 1999c). Te2 and Te3 also send projections to the amygdala
(Romanski and LeDoux, 1993a; Shi and Cassel, 1997). Te3 has been shown to play an
important role in discriminating novel complex sounds (Wan et al., 2001).
Layers I-IV
Layer I is the most superficial layer of the AC and contains a very small number of
neurons. Its primary sources of input are from MGm and cortical cells from within (Winer, 1992;
Winer and Schreiner, 2005). Layer II lies below Layer I, and contains many pyramidal and nonpyramidal shaped neurons (Winer, 1992). This layer projects to the neighbouring layers III and
IV. Like Layer II, Layer III also has many pyramidal and non-pyramidal neurons. This layer
receives intrinsic input from the neighbouring ipsilateral Layer II, contralateral AC, and MGv.
Layer IV is the thinnest among all the six layers of the AC and is densely packed with nonpyramidal small neurons (Games and Winer, 1988). This layer receives direct projections from
MGv and Layer II (Winer and Schreiner, 2005).
Layer V
This is the thickest layer in the AC and contains many pyramidal neurons with long
apical dendrites that project perpendicular to the surface of the brain. This layer receives inputs
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from ipsilateral Layers III and IV, and from MG. Output from this layer varies according to the
neuron type that is projecting. Large neurons with long apical dendrites, located deep within the
layer, project to the ICd and ICx on both sides of the brain. Small neurons, located in the
superficial region of the layer, project to the contralateral AC. Medium sized neurons project to
the AC and IC (Games and Winer, 1988). Neurons in the most superficial and the deepest
regions of this layer project to the ipsilateral MGv and MGd (Winer and Prieto, 2001).
Layer VI
This layer contains pyramidal and non-pyramidal neurons which are small in size and
very densely packed (Schofield, 2009). Input to this layer comes from MGm (Winer and
Schreiner, 2005). Output from this layer is exclusive to the ipsilateral structures including MGd,
MGm, ICd, and ICx. It also weakly projects to the neighbouring Layer V, the SOC, and CN
(Schofield, 2009).
1.4 Neurotransmission in the CAS
Neural processing of acoustic information is dependent on the transmission of signals
among auditory neurons. This transmission is dependent on molecules called neurotransmitters.
In the central auditory system, major neurotransmitters leading to an excitatory effect is
glutamate while major neurotransmitter leading to an inhibitory effect include glycine and
gamma-aminobutyric acid (GABA). Binding of a neurotransmitter to its specific receptor can
lead to either excitation or inhibition in a neuron on which a receptor is located. The receptors
can be of two types: ionotropic or metabotropic.
Ionotropic receptors are linked directly to ion channels. Their extracellular domain has a
site for ligand binding. Their membrane-spanning domain is an ion channel. Upon
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neurotransmitter binding, the ion channel is opened, allowing for flow of ions. Ionotropic
receptors are also called ligand-gated ion channels. Because these receptors can open ion
channels directly after neurotransmitter binding, they mediate rapid post-synaptic effects. They
can be activated within a millisecond of action potential arrival, and only remain activated for a
few tens of milliseconds (Purves et al., 2001).
Metabotropic receptors are not directly linked to ion channels. Instead, they modulate ion
channels through an intracellular signalling cascade. Metabotropic receptors are linked to
molecules called G-proteins. The extracellular domain of metabotropic receptors has a binding
site for a neurotransmitter. The intracellular domain binds to G-proteins. Binding of the
neurotransmitter causes the activation and subsequent dissociation of G-proteins from the
receptor. The dissociated G-proteins can directly interact with an ion channel, or can lead to the
production of intracellular second messengers and activate a cascade of events and eventually
modify ion channels. Because their mode of action involves multiple steps and proteins, they
produce slower responses ranging from hundreds of milliseconds to minutes or longer.
Metabotropic receptors are also called G-protein-coupled receptors (Purves et al., 2001).
1.4.1 Glutamatergic neurotransmission
Glutamate is the most abundant neurotransmitter in the central nervous system
(Silverthorn, 2007). The neurotransmitter is stored in vesicles in the terminal of an axon of a
neuron, and is released upon the depolarization of the cell membrane of the terminal by an action
potential. The binding of glutamate with its post-synaptic receptors can lead to either excitatory
or inhibitory effect, depending on the specific subtypes of the receptors. Glutamate is usually
considered an excitatory neurotransmitter, as in most cases its effect is associated with
depolarization of the cell membrane. In the central nervous system, there are two major
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categories of glutamatergic receptors, namely the ionotropic galutamatergic receptors and the
metabotropic glutamatergic receptors.
Major types of glutamatergic receptors in the central auditory system are ionotropic.
They include the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and the Nmethyl-D-aspartic acid (NMDA) receptors (Silverthorn, 2007).
1.4.1.1 AMPA receptors
These ionotropic receptors are gated ion channels that are permeable to sodium and
potassium ions. Upon binding by glutamate, the channel opens and allows sodium ions to flow
into the cell and potassium ions to flow out of the cell, resulting in a net effect of depolarization
of the cell membrane and production of excitatory post-synaptic potentials or EPSPs. These
receptors have a fast time course of activation, and are important for processing information
associated with changes, e.g. the acoustic onset of a sound (Zhang and Kelly, 2001).
1.4.1.2 NMDA receptors
Similar to the AMPA receptors, NMDA receptors are gated ion channels that are
permeable to sodium and potassium ions. In addition to those ions, NMDA channels are also
permeable to calcium ions. Under normal resting potentials, the channel pore of an NMDA
receptor is blocked by magnesium ions. This blockage prevents fluxes of ions. The blockage can
be removed by a slight depolarization of the membrane, which is provided by the activation of
nearby AMPA receptors. When the magnesium ions are removed, cations including calcium ions
can move through the channel, causing further depolarization of the membrane. In contrast to the
AMPA receptors, the NMDA receptors are important for mediating responses to sustained sound
stimulation (e.g., the plateau of a tune burst) (Zhang and Kelly, 2001; Kelly and Zhang 2002).
Calcium ions can also act as second messengers which can activate an intracellular signalling
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cascade, ultimately resulting in increased excitability of the neuron. The effect of calcium on the
intracellular signalling cascade last for hours or longer and results in enhanced excitatory
responses in a postsynaptic cell. This enhancement of excitatory responses is referred to as longterm potentiation (Silverthorn, 2007).
1.4.2 GABAergic neurotransmission
GABA is the major inhibitory neurotransmitter in the brain. Neurons producing GABA
or responding to GABA are referred to as GABAergic. Approximately 40% of all synapses in the
brain are GABAergic, alluding to its importance in the central nervous system (Malcangio et al.,
1996). GABA is a neutral amino acid synthesized from glutamate by the action of the enzyme
glutamic acid decarboxylase (Fagg and Foster, 1983; Ribak et al., 1979). GABA
neurotransmitter is stored in vesicles by a sodium-independent, ATP-dependant transport system.
Upon depolarization, GABA is released into the synaptic cleft where it can interact with postsynaptic GABA receptors. GABA is inactivated by diffusion, and by a high-affinity sodiumdependant transport system that transports GABA into synaptic terminals and glial cells (Fykse
and Fonnum, 1988; Hell et al., 1988).
Upon release, GABA can activate three different types of receptors; GABAA, GABAB,
and GABAC (Enna, 2001). GABAA and GABAB receptors exist in the central nervous system of
the rat and other animals, and are present at high concentrations in the hippocampus, thalamus,
cortex, and cerebellum (Chu et al., 1990; Wamsley et al., 1986; McCabe and Wamsley, 1986;
Zezula et al., 1988). GABAC receptors have been found mostly in the retina of vertebrae
(Bormann and Feigesnspan, 1995). GABAA receptors are present at high levels in the frontal
cortex, the hippocampus, the granule cell layer of cerebellum, the thalamic medial geniculate
nucleus, and the olfactory bulb. GABAB receptors are present at high levels in the molecular
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layer of cerebellum, interpeduncular nucleus, frontal cortex, anterior olfactory nucleus, and
thalamic nuclei (Bowery et al., 1987; Young and Chu, 1990). Studies have also found a high
level of expression of GABAB receptors in auditory structures of rats (Bowery et al., 1987;
Charles et al., 2001; Jamal et al., 2011, 2012; Milbrandt et al., 1994). GABAergic receptors are
very important for the functions of the brain. These receptors are involved in numerous processes
such as appetite regulation (Morley, 1980; Hansen and Ferreira, 1986; Kelly and Grossman,
1979; Lenin Kamatachi et al., 1984, 1986), cardiovascular regulation (Chahl and Walker, 1980;
Persson and Henning, 1980; Robinson et al., 1986), depression (Berretini et al., 1983; Gerner and
Hare, 1981; Gold et al., 1980; Lloyd et al., 1983; Petty and Sherman, 1981, 1984), seizures
(Lloyd et al., 1986; Manyam et al., 1980; Meldrum, 1975; Scmidt and Loscher, 1981; Tower,
1960; Wood and Peesket, 1973; Wood et al., 1979; Worms and Lloyd, 1981), anxiety (Iverson,
1983; Macdonald et al., 1986; Olsen and Snowman, 1982; Study and Barker, 1982), and stress
(Biggio et al., 1981; Otero-Losada, 1988; Schwartz et al., 1987; Skerrit et al., 1981).
1.4.2.1 GABAA receptors
GABAA receptors are ionotropic receptors. These receptors can be modulated by
benzodiazepines and barbiturates, and are sensitive to the alkaloid convulsant bicuculline. These
receptors are membrane associated, ligand-gated chloride channels that allow influx of chloride
ions upon opening. Activation of a GABAA receptor leads to hyperpolarisation of the cell
membrane and a fast inhibitory response (Huang, 2006). GABAA receptors outnumber GABAB
receptors in most areas of the brain (Chu et al., 1990).
1.4.2.2 GABAB receptors
GABAB receptors are metabotropic receptors that are linked to G-proteins and indirectly
affect Ca2+ and K+ channel conductance in the membrane (Figure 3a). GABAB receptors are
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located either pre-synaptically or post-synaptically. Pre-synaptic GABAB receptors inhibit the
release of GABA or glutamate neurotransmitters (Kornau, 2006; Ma et al., 2002), thereby
regulating either inhibitory or excitatory neurotransmission. For presynaptic GABAB receptors,
binding by GABA causes the βγ-subunit of the G-protein to dissociate from the α-subunit,
leading to modification of voltage-dependant Ca2+ channels. This modification reduces Ca2+
influx into a cell and subsequently decreases neurotransmitter release from a pre-synaptic
terminal (Ikeda, 1996; Herlitze et al., 1996).
Activation of post-synaptic GABAB receptors leads to prolonged inhibition through the
action of the βγ-subunits dissociated from the G-protein. The dissociated βγ-subunits activates
inward rectifier K+ channels (GIRK), thereby causes hyperpolarization of a postsynaptic neuron
(Luscher et al., 1997; Ulrich and Bettler, 2007). The βγ-subunit also activates phospholipase C
which in turn activates protein kinase C, thereby triggering a signalling cascade that can
modulate neuronal function (Blank et al., 1992; Selbie and Hill, 1998). The α-subunit of the Gprotein can modulate cAMP production, initiating a signalling cascade that involves many
intracellular proteins and events. This way, GABAB receptors can have long-term effects on
neuronal activity (Bowery et al., 2002).
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Figure 3. General structure and mechanism of action of metabotropic GABAB receptor. (A) The
receptor is coupled with a G-protein which dissociates upon receptor activation by GABA
neurotransmitter. The dissociated G-protein subunits can directly affect ion channels and can
modulate adenylyl cyclase activity. (B) The two known isoforms of the GABABR1 subunit. The
GABAB1a subunit has two sushi domains on its N-terminus.
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1.4.2.2.1 GABAB receptor subunits
A functional GABAB receptor is a heterodimer, consisting of a GABABR1 and a
GABABR2 subunit (Figure 4). These subunits interact through their coiled-coil domains and
form a functional GABAB receptor. Both subunits are very similar in conformation, with each
containing a heptahelical domain (HD) and a venus flytrap (VFT) module (Pin et al., 2004).
GABABR1 subunit has two splice variants. These are the GABABR1α and GABABR1β
subunits. The two splice variants are identical in structure except for the presence of repeating
sequences on the N-terminus of the GABABR1α splice variant (Figure 3b). These repeating
sequences are known as sushi domains and are evolutionarily conserved (Huang, 2006). The
exact function of the sushi domains on the GABABR1α subunit is not known, but it is believed
that they serve to work as axonal targeting signals that guide the subunit towards pre-synaptic
terminals to regulate the release of glutamate. GABABR1β subunit binds to potassium channels
and allows K+ ions to flow, and is important for functioning post-synaptic GABAB receptors.
GABABR2 subunit may have isoforms as well, but they have not been characterized (Chalifoux
and Carter, 2011).
Both subunits and their variants are formed in the endoplasmic reticulum (ER) (Ige et al.,
2000). The GABABR1 subunit has a retention signal and remains in the ER after production
(Restituito et al., 2005). The GABABR2 subunit is needed for the release and subsequent
trafficking of the GABABR1 subunit from ER to its destination. Upon binding between the two
subunits, the GABABR2 subunit masks the retention signal on GABABR1, thus allowing the
heterodimer to leave the ER and reach the plasma membrane (Pin et al., 2004; Restituito et al.,
2005).
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Figure 4. Binding structure of a functional GABAB receptor. The GABABR1 subunit is on the left
in blue. The GABABR2 subunit is on the right in yellow. Each subunit is composed of a venus
flytrap (VFT) module and a heptahelical domain (HD). The VFT of GABABR1 binds GABA
neurotransmitter. The HD of GABABR2 is associated with a G-protein which is activated when
GABABR1 binds GABA (Pin et al., 2004).
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The presence of both subunits is needed to form a functional GABAB receptor. Studies
have shown that on their own, both subunits have no activity. GABABR2 is able to leave the ER
and go to the plasma membrane but is unable to have any physiological effect on the membrane.
Without the GABABR2 subunit, GABABR1 subunit can be trafficked to the plasma membrane
when the retention signal is blocked due to mutation or removal. However, the subunit is nonfunctional by itself (Pin et al., 2004). This is because each subunit has a specific function in the
GABAB heterodimer. GABABR1 subunit has the binding domain for the neurotransmitter GABA
on its VTF module. GABABR2 subunit is associated with the G-protein via its HD domain
(Enna, 2001). When the two subunits interact, the affinity of GABABR1 for GABA
neurotransmitter is increased so that when it binds GABA, the G-protein associated with the
GABABR2 subunit is activated and can have various downstream affects (Pin et al., 2004; Enna,
2001).
1.4.2.2.2 Distribution of GABAB receptors in the CAS
Autoradiographical and immunohistochemical studies have revealed a high level of
expression of GABAB receptors in most auditory structures. Using the autoradiographic
technique, Fubara et al (1996) studied the expression of GABAB receptors in the big brown bat’s
central auditory system and found that the expression of the receptor to be high in AC, MG, and
the dorsal nucleus of IC. The expression in ventral IC, NLL, SOC, and CN was relatively low.
Similar results were reported by other researchers based on research using the same technique
conducted in specific structures of other species, including guinea pig's CN (Juiz et at., 1994),
and the rat's IC (Mibrandt et al., 1994).
The autoradiography results were supported by immunohistochemistry results that
examined the expression of the GABAB receptor in the entire auditory system (Charles et al.,
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2001, Jamal et al., 2011). These results reported a high level of the receptor in the AC and MG,
intermediate level in the IC, and low levels in the NLL, SOC, and CN. Other
immunohistochemistry studies found GABAB expression in the dorsal CN, and medial SOC
(Lujan et al., 2004; Hassfurth et al., 2010).
Immunohistochemistry studies also gave information about the regional as well as
cellular localizations of GABAB receptors in central auditory structures. Qualitative results from
Jamal et al., (2011) showed that there were regional differences in the level of the receptor in a
few structures. AC and MG showed no significant differences in receptor labelling across their
subdivisions. In the IC, receptor expression was the highest in the ICd and intermediate in the
ICc and ICx. In the CN, receptor expression was high in the DCN compared to VCN. Jamal et
al., (2012) quantified receptor expression in the IC and reported a high level of expression in the
ICd and an intermediate level in ICc and ICx. The study also found that receptor expression was
similarly high in cell bodies across all the IC subdivisions. The differences in receptor expression
were seen in the neuropil i.e. the region surrounding the cell bodies. Neuropil contains the axons
and dendrites of cell bodies. While the level of labeling in the neuropil is higher in the ICd, the
level is lower in the ICc and ICx.
1.4.2.2.3 Functions of the GABAB receptors in the CAS
Physiological studies have supported results from the autoradiography and
immunohistochemistry studies showing the existence of GABAB receptors in the CN (Lim et al.,
2000), SOC (Isaacson, 1998; Sakaba and Neher, 2003; Yamauchi et al., 2000), IC (Faingold et
al., 1989; Ma et al., 2002; Sun et al., 2006; Sun and Wu, 2009; Vaughan et al; 1996; Zhang and
Wu, 2000), MG (Peruzzi et al., 1997; Bartlett and Smith, 1999), and AC (Buonomano and
Merzenich, 1998; Metherate and Ashe, 1994; Brandowski et al, 2001).
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In the CN, using antagonists of GABAB receptors decreased the amplitude of evoked
IPSCs, leading researchers to believe that activation of these receptors can reduce
neurotransmitter release (Lim et al., 2000). In vivo extracellular recordings from IC showed that
activation of GABAB receptors reduced responses to sounds, whereas antagonizing these
receptors increased responses to tones and sinusoidally amplitude modulated sounds (Faingold et
al., 1989; Vaughan et al., 1996; Szczepanial and Moller, 1996). Yamauchi and colleagues (1989)
recorded the activity of neurons in the IC and reported that blocking GABAB receptors in the IC
caused epileptiform burst discharge of action potentials. In the MG, GABAB receptors were
shown to be important for regulating the firing patterns of neurons (Peruzzi et al., 1997). In the
AC, GABAB receptors were found to be important for regulating synaptic activity mediated by
NMDA receptors (Metherate and Ashe, 1994). GABA release also improved temporal
processing in the AC (Jones, 1993; Schulze and Langner, 1999; Wang et al., 2000). These
studies indicate that GABAB receptors are highly involved in auditory processing.
1.5 Normal auditory functioning requires a balance between excitation and inhibition
The function of the central auditory system is dependent not only on excitation but also
on inhibition. A balance between excitatory and inhibitory neurotransmission is important for the
function. A disruption of this balance can manifest itself as various auditory disorders or hearing
impairments.
Loss of this inhibition can have pathological behavioural consequences (Bauer et al.,
1999; Gerken et al., 1984). At the physiological level, a reduction in inhibition can lead to
hyperactivity in the CAS (Salvi et al., 1990; 2000). The hyperactivity was demonstrated by an
increase in the spontaneous firing rate of neurons in the IC (Jastreboff and Sasaki, 1986; Chen
and Jastreboff, 1995) and the AC (Kenmochi and Eggermont, 1997; Eggermont and Kenmochi,
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1998). Decreased inhibition also causes synchronous firing of groups of neurons, which can
change auditory neural processing (Ochi and Eggermont, 1997). Decrease in inhibition can also
alters gene expression in the AC, causing aberrant plastic changes in the AC, and subsequently
alter auditory perception (Panford-Walsh et al., 2008). Reduction in inhibitory neurotransmission
can also lead to an increase in excitation (Gong et al., 2008), which can have various detrimental
effects on the CAS. Increased excitatory neurotransmission has been shown to produce
epileptiform firing in the auditory nerve fibers and alter auditory perception (Guitton et al., 2003;
Guitton and Puel, 2004). Increased excitation can cause swelling of the ANF dendrites and lead
to membrane disruption (Puel, 1995). Prolonged excitation in the AC can cause shifts in the
receptive fields of neurons (Scholl and Wehr, 2008). Among hearing disorders, tinnitus may also
be related to an imbalance between excitation and inhibition.
1.6 Tinnitus
Tinnitus is a phantom sensation of sound in the absence of an external sound stimulus.
Such sensation can be experienced as constant buzzing, hissing, or whistling. Tinnitus can
interfere with an individual's ability to sleep, hear, and work. Almost all adults in the general
population experience transient tinnitus at some point in their life. However, 6-20% of adult
North American population suffers from chronic tinnitus, which can be devastating to a person's
quality of life (Heller, 2003). Only twenty-five percept of people suffering from chronic tinnitus
seeks medical treatment. Tinnitus is detrimental to a person's quality of life because it is often
accompanied by maladies such as migraines, dizziness, hearing loss, and decreased sound
tolerance. Forty percent of patients suffering from tinnitus also suffer from hyperacusis, i.e.,
over-amplification of environmental sounds, and phonophobia, i.e., fear of environmental
sounds. Tinnitus is more common in aging population and among females. Furthermore, its
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prevalence is significantly higher in pregnant females than non-pregnant females (Axelsson and
Ringdahl, 1989; Lockwood et al., 2002). There are two types of tinnitus, called objective tinnitus
and subjective tinnitus.
1.6.1 Objective vs. subjective tinnitus
Objective tinnitus is relatively rare. It is defined by the presence of an actual sound from
inside the body, which leads to the perception of the sound through normal hearing mechanisms.
The actual sound can be generated by a pulsing blood vessel near the middle or inner ear
(Weissman and Hirsch, 2000; Liyanage et a., 2006; Sonmez et al., 2007), involuntary muscle
contractions in the middle ear (Abdul-Baqi, 2004; Howsam et al., 2005), or inner ear hair cell
stimulation (Chandler, 1983). As such, objective tinnitus is the normal perception of an abnormal
sound in the body, and is believed to originate in the peripheral auditory system.
Subjective tinnitus is a common form of tinnitus. It differs from objective tinnitus in that
there is no actual, overt sound present. Many researchers believe that subjective tinnitus is
associated with changes in the peripheral and/or central auditory system (Moller, 2003;
Lockwood et al., 2002; Jastreboff, 1990). Since many patients reported tinnitus in one but not
both ears, it was believed for many years that tinnitus may originate from a peripheral source
such as the cochlea. However, clinical observations have showed that this cannot account for all
forms of subjective tinnitus. Studies found that blocking auditory inputs to the brain did not
diminish tinnitus, indicating that central mechanisms must be involved in tinnitus (Berliner et al.,
1992; Barrs and Brackman, 1984; House and Brackman, 1981; Kaltenbach et al., 2005).
1.6.2 Inducers of tinnitus
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There are many inducers of tinnitus in the human population. These inducers can be
divided into non-medical and medical ones. The most common non-medical cause of tinnitus is
loud noise. Individuals who are exposed to loud noises on regular basis e.g. working at a
construction site, or if they are exposed to it once e.g. at a concert, can develop tinnitus.
Medical inducers of tinnitus include various over-the-counter and prescription drugs.
Many antibiotics, anti-depressants, anti-malarial drugs, anti-inflammatory drugs, diuretics, and
certain cancer drugs have been shown to induce tinnitus in humans. Of the above medications,
anti-inflammatory drugs are the most prevalent inducers of tinnitus in humans. Aspirin is an
example of such a drug. It is one of the most consumed drugs in the world (PharminfoNet, 1994,
1999; Vane et al., 1998). One hundred and twenty billion pills of Aspirin are prescribed in North
America each year (Warner and Mitchell, 2002).
Aspirin is an odorless, white, powdery substance which is highly soluble in lipids and
slightly soluble in water. Upon exposure to moisture, it rapidly hydrolyzes into salicylic acids
and acetic acids, with 68% of oral dose reaching systemic circulation (Rowland et al., 1972).
Peak plasma levels of salicylic acid are detected 1-2 hours after aspirin ingestion. Salicylic acid
is widely distributed to all the tissues in the body including CNS, liver, renal cortex, heart, and
lungs, and has a half-life of 6 hours. Salicylic acid is excreted in the urine in a pH dependant
manner. Renal excretion increases from 5% to 80% as urinary pH rises above 6.5 (Bayer Corp.
USA).
Aspirin is used for treating a variety of maladies e.g. ischemic stroke, acute myocardial
infarction, angina pectoris, and rheumatoid diseases such as arthritis. Aspirin acts by inhibiting
the synthesis of prostaglandins, and prevents platelet aggregation by inactivating cyclo-
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oxygenase enzyme. Aspirin has also been shown to inhibit inflammatory mediators by nonspecifically suppressing cyclo-oxygenase activity in peripheral tissue, causing gastric irritation as
a side effect. Other side effects of aspirin include coagulation abnormalities due to inhibition of
platelet function, stomach pain, nausea, vomiting, and gross gastrointestinal bleeding, and
auditory sensorineural alterations such as tinnitus and hyperacusis. A detailed description of the
side effects of Aspirin can be seen in Table 1 (Bayer Corp. USA).
1.6.3 Sodium salicylate (SS)
Salicylate is one of the metabolites of Aspirin (Acetylsalicylic acid) (Figure 5), and has
been shown to cause auditory abnormalities in patients. Early reports of salicylate ototoxicity
were given by Muller (1877) who observed the adverse ototoxic effects of salicylate in patients
being treated for rheumatoid arthritis. Since then, many studies have been conducted in humans
and animals to study the effects of Aspirin and salicylate.
1.6.3.1 Effects of salicylic drugs on hearing: Studies conducted with human patients
Many studies were conducted with patients taking either aspirin or salicylate to determine
whether tinnitus was induced, and the plasma salicylate level at which the phantom auditory
sensation is induced. These studies found that there was individual variability amongst subjects.
Jagar and Alway (1946) found that tinnitus appeared in 34 out of 38 patients being treated with
salicylate injections for several weeks. Tinnitus was seen at blood salicylate levels as low as 200
mg/L. Similar findings were reported by Graham and Parker (1948) who studied oral salicylate
therapy in 40 rheumatic patients and 30 non-rheumatic patients. They found that most subjects
experienced deafness at plasma salicylate levels averaging 250 mg/L. Further studies in human
subjects receiving oral salicylate treatment (Myers et al., 1965, McCabe and Day, 1965; Mongan
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Figure 5. Molecular structure of aspirin (acetylsalicylic acid) and sodium salicylate.
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Table 1: Adverse reactions to Aspirin/salicylate ingestion
Body as a whole

Fever, hypothermia, thirst

Cardiovascular

Dysrhythmia, hypotension, tachycardia

Central Nervous System

Agitation, cerebral edema, coma, confusion, dizziness, headaches,
subdural or intracranial hemorrhage, lethargy, and seizures

Fluid and electrolyte

Dehydration, hyperkalemia, metabolic acidosis, respiratory
alkalosis

Gastrointestinal

Dyspepsia, GI tract bleeding, ulceration and perforation, nausea,
vomiting, hepatitis, pancreatitis, Reye's Syndrome, transient
elevation of hepatic enzymes

Hematological

Prolongation of prothrombin time, disseminated intravascular
coagulation, coagulopathy, thrombocytopenia

Hypersensitivity

Acute anaphylaxis, angioedema, asthma, bronchospasm, laryngeal
edema, urticaria

Musculoskeletal

Rhabdomylosis

Metabolism

Hypoglycemia in children, hyperglycemia in adults

Reproductive

Prolonged pregnancy and labor, stillbirths, lower birth weight
infants, antepartum and postpartum bleeding

Respiratory

Hyperpnea, pulmonary edema, tachypnea

Special senses

Hearing loss, tinnitus

Urogenital

Interstitial nephritis, papillary necrosis, proteinuria, renal
insufficiency and failure

33

et al., 1973; Halla and Hardin, 1988; Halla et al., 1991; Hicks and Bacon, 1999; and Janssen at
al., 2000) have confirmed that patients experience tinnitus at average blood salicylate plasma
levels of 200 mg/L - 250 mg/L. These studies also reported that the minimum plasma salicylate
levels that induced tinnitus were almost always below 100 mg/L (Jager and Alway, 1946;
Graham and Parker, 1948). For salicylate-induced tinnitus, the pitch reported by patients was
always in the high frequency range, and showed a linear increase with plasma salicylate levels
(Alway, 1946; Graham and Parker, 1948).
1.6.3.2 Effects of salicylic drugs on hearing: Studies conducted with animals
Animal models of salicylate-induced tinnitus have been developed and behavioural
paradigms as well as neurophysiological methods have been used to study the neurobiological
bases of the auditory phantom sensation. Jastreboff and his colleagues (Jastreboff et al, 1988a,
1988b; Jastreboff and Sasaki, 1994) modified the operant conditioning procedure used by Estes
and Skinner (1941) and used it in the study of tinnitus. Jastreboff et al. (1988a, 1988b) used a
combination of water-deprivation and electric foot shocks to establish a behavioral paradigm for
evaluating the effect of salicylate on rat’s hearing. Experimental subjects were trained to
suppress licking of a licking spout in the presence of silence. These animals were tested to find
how systemic application of salicylate affect the suppression of licking during the silent period.
Using this behavioural method, the researchers found that subcutaneous injections of
300mg/kg/day sodium salicylate (SS) could reliably induce a tinnitus-like behavior in rats. The
pitch of tinnitus sensation was about 10 to 11 kHz, values consistent with those from human
subjects with high pitch tinnitus.
Jastreboff and his colleagues also studied the dependence of loudness of tinnitus on the
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dose of sodium salicylate. A strong correlation was found between the dose and the loudness of
tinnitus when the drug was applied at doses of 50-300mg/kg. The researchers also measured
blood salicylate levels of the animals and found that the data fit extremely well with the human
data (Jastreboff et al., 1988b).
Recently, other researchers developed other behavioural paradigms to assess the presence
and pitch of tinnitus (Lobarinas et al., 2004; Yang et al., 2007; Turner and Parrish, 2008; Ralli et
al., 2010, and Kizawa et al. 2010). Their results basically confirmed findings by Jestreboff and
his colleagues and have approximated the pitch of tinnitus to 16 kHz.
1.7 Effect of Sodium Salicylate (SS) on peripheral and central auditory systems
As indicated in section 1.6.3.2, many studies have shown that application of SS can
induce tinnitus-like behaviour in animals (Jastreboff et al, 1988a; 1988b; Jastreboff and Sasaki,
1994). The tinnitus-like behaviour persisted even when the cochlea or the auditory nerve were
disconnected from the brain (Berliner et al., 1992), leading researchers to believe that tinnitus
involved changes in both the peripheral and the central auditory systems.
1.7.1 Effect of SS on peripheral auditory system
Researchers studied the effect of SS by recording compound action potentials (CAP) of
auditory nerve fibers (ANFs). Results indicate that SS application results in a reduction in the
output from cochlea (Cazals, 2000). Muller and colleagues (2003) measured changes in the
activity in the cochlea and auditory nerve fibbers after systemic SS injection. They found that
after the application of 250mg/kg of SS, the output from peripheral structures was significantly
decreased. Muller et al., (2009) directly applied SS to cochlea and found that sound-evoked
activity in the cochlea was decreased. Studies by other researchers (Shehata et al., 1991, Oliver
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et al., 2000; Chen at al., 2010) showed that SS application decreased the electromotility of the
outer hair cells (OHC) in the ear, thus decreasing the signal output from the ear to the central
auditory system. This supplemented the point that tinnitus was not a result of increased activity
in the ear, and instead had neural correlates in the central auditory system.
1.7.2 Effect of SS on the Central Auditory System
1.7.2.1 Effect of SS on CN
CN is the first structure in the ascending auditory pathway and receives direct inputs from
the peripheral auditory system. Previous studies have suggested that CN might play a key role in
the generation of salicylate-induced tinnitus (Brozoski et al., 2002; Kaltenbach and Godfrey,
2008; Shore et al., 2007). Basta et al. (2008) conducted experiments using brain slice
preparations. They perfused the tissue containing CN with salicylate solution and used electrodes
to record the activity of neurons. They found increased activity in the CN after SS application
(Basta et al., 2008). Similar brain slice experiments were conducted by Wei at al. (2010), who
also reported an increase in spontaneous firing rate of neurons in the CN after SS application.
Holt and colleagues (2010) used manganese enhanced functional magnetic resonance imaging
(MEMRI) to map the activity in auditory structures after systemic salicylate injections in rats.
They found a significant increase in activity in the dorsal cochlear nucleus (DCN) but no change
in the ventral cochlear nucleus (VCN). All the results above supports the involvement of the CN
in salicylate induced tinnitus.
1.7.2.2 Effect of SS on IC
IC is a mid-brain structure, and is a major auditory processing centre. It is the target of
ascending inputs from lower auditory structures as well as descending inputs from higher
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auditory structures. Because of its importance in auditory processing, it has been a major focus in
the study of neural mechanisms responsible for tinnitus (Manabe et al., 1997; Moller, 1995;
Bauer et al. 2000). Wu and colleagues (2003) found that after SS application, c-fos expression in
IC was increased, implying increased activity. Basta and Ernst (2004) worked with brain slices
perfused with salicylate-containing solution, and found that the spontaneous activity of neurons
in the IC was significantly increased after SS application. Increases in spontaneous activity were
also found in studies involving in vivo animal preparations (Jastreboff and Sasaki, 1986); Chen
and Jastreboff, 1995); Manabe et al., 1997). In these studies, SS was injected systemically and an
increase in the spontaneous firing rate was found in neurons in the ICc and ICx after drug
application. Holt et al. (2010) used the MEMRI technique to measure the activity in IC after
systemic salicylate injections and found a significant increase in the ICd. These studies support
that the IC serves as a contributor to the phenomenon of tinnitus.
1.7.2.3 Effect of SS on MG
Limited research has been conducted to study the effect of SS on the MG. Basta and
colleagues (2008) conducted a brain slice study with MG and found a change in the spontaneous
firing rate of neurons. These researchers perfused the brain slice with salicylate perfusate and
recorded the spontaneous activity of neurons in the dorsal and ventral parts of the MG, and found
that neurons increased their spontaneous firing rate after local application of SS. This change in
firing rate was correlated with the concentration of SS, with higher concentrations eliciting a
greater percent change in the firing rate of neurons (Basta et al., 2008).
1.7.2.4 Effect of SS on AC
AC has been a target of many studies in the tinnitus research field, with most researchers
reporting a change in the neuronal spontaneous activity after salicylate application. Basta and
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colleagues (2008) found that salicylate caused an increase in spontaneous firing rate in neurons
in the AC. This increase was more apparent at higher concentrations of SS. Yang et al. (2007)
recorded the activity of neurons in a live rat after systemic salicylate application, and found that
sound-evoked neural activity in the AC was increased after SS application. Lu et al. (2011)
measured the activity of AC neurons after systemic and local application of SS. They reported
that after either application, the amplitude of sound-evoked neural activity was increased in the
AC neurons, but the spontaneous activity was reduced.
1.8 Current understanding of neural mechanisms responsible for tinnitus
Available results related to the effect of SS on neural activity in auditory structures
suggest that the tinnitus sensation may be due to a tip of balance between excitation and
inhibition i.e. either an increase in excitatory neural activity or a decrease in inhibitory neural
activity. Tinnitus may also be related to an increase in spontaneous firing of auditory neurons, or
an enhancement in synchronization of activity among different auditory neurons. The latter two
might also be a result of an imbalance between excitation and inhibition.
The hypothesis that dysregulation between excitatory and inhibitory activity might be a
cause of tinnitus is very commonly invoked, and there are many studies to support it. Holt and
colleagues (2010) used manganese-enhanced MRI to measure the activity of neurons in CN and
IC after tinnitus induction using SS. They found an increase in neural activity in the DCN and
ICd in rats that displayed tinnitus-like behaviour. In vitro physiological studies examining the
immediate effect of SS showed that SS application reduced GABA-mediated inhibition in CAS,
leading to increased hyperexcitability (Wang et al., 2008; Gong et al., 2008). A reduction in
GABAergic inhibition was reported by Sun et al., (2009) and Lu et al. (2011) as the cause of
increase activity in the AC. Zou and Shang (2012) found a significant decrease in the levels of
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GABAA receptor and the enzyme GAD in CAS after salicylate application. Since GAD catalyzes
the production of GABA neurotransmitter, a reduction in GAD levels could translate as a
reduction in the level of GABA (Zou and Shang, 2012). Similar decreases in GABAA receptor
expression and GAD levels have also been reported by another study (Basta et al., 2000). A
significant decrease in the number of GABAA receptor binding sites has been found in the IC
after SS application. It has been suggested that these changes result in decrease in inhibition in
the CAS and manifest as perception of tinnitus (Basta et al., 2000).
Decreased inhibition can also lead to increases in spontaneous firing of neurons in the
CAS. Increased spontaneous activity following salicylate treatment has been observed in various
structures including the auditory nerve, DCN (Kaltenback et al., 1998, 2000, 2002; Brozoski et
al., 2002; Chang et al., 2002), IC, and secondary auditory cortex (Mulheran and Evans, 1999;
Manabe et al., 1997; Jastreboff and Sasaki, 1986; Eggermont and Kenmochi, 1998). These
increases in spontaneous activity were measured using physiological methods. While sounddriven activity are responsible for normal hearing (Clark, 2008; Colletti et al., 2009), an
increases in spontaneous activity after SS application might lead to a phantom sensation of
sound, i.e., tinnitus.
Decreased inhibition can also enhance neural synchrony i.e. synchronous firing of groups
of neurons. Synchronous discharges have the potential to drive post-synaptic targets at higher
auditory structures (Roberts et al., 2008; 2010). Evidence of increased neural synchrony and
increased bursting activity has been found following systemic application of SS. Chronic
increases in bursting activity was observed in the IC after salicylate treatment (Chen and
Jastreboff, 1995; Kwon et al., 1999). Increased synchrony of discharge across neural populations
was seen in the auditory nerve after salicylate treatment (Cazals et al., 1998). In human patients

39

suffering from tinnitus, electroencephalography and magnetoencephalography results showed
abnormal synchronous activity between cortical areas of tinnitus patients (Weisz et al., 2005;
Schlee et al., 2009). It is believed that increased synchronous activity and burst finding might
magnify the perceptual weight of tinnitus sensation.
SS can cross the blood-brain barrier and affect neurons directly (Silverstein et al., 1967).
As discussed above, effects of the drug can be immediate and associated with modifications of
physiological processes such as neurotransmission and/or opening and closing of ion channels.
In addition to these changes, SS might also affect other cellular mechanisms such as the
expression of proteins. Zou and Shang (2012) reported that SS could reduce the level of mRNA
of the GABAAα1 subunit as well as that of the enzyme GAD67. It has been found that SS can
increase the level of mRNA of brain-derived neurotrophic factor in the cochlea and decrease the
expression of Arg3.1, an activity dependant cytoskeletal protein, in the AC (Panford-Walsh et
al., 2008). An increase in the level of mRNA of tumor necrosis factor-α and that of NMDA
receptor subunit 2A has been found in the CN of rats after SS administration (Hu et al., 2014).
Existing results therefore indicate that SS can cause changes in the expression of proteins,
including those related to inhibitory neurotransmission mediated by the GABAA receptors and
those related to excitatory neurotransmission mediated by the NMDA receptors. Most of these
changes are seen after a period of 2-3 hours and may reflect homeostatic regulation of the level
of activity by auditory neurons (Panford-Walsh et al., 2008; Hu et al., 2014).
It has yet to be found whether the level of the GABAB receptor can be affected by SS.
The GABAB receptor has a relatively high level of expression in the structures possibly
responsible for the induction/generation of tinnitus. The receptor can mediate slow inhibitory
post-synaptic potentials as well as modulate the release of both inhibitory and excitatory

40

neurotransmitters. Therefore, it might play a regulatory role in maintaining a proper level of
activity in the auditory system, similar to what it does in other nervous systems (Malcangio and
Bowery, 1996). Behavioural studies have shown that the peak effect of SS occurs 3 hours after
systemic SS application. This time course coincides with the time frame associated with change
in the expression of many proteins. Therefore a possibility exists that the central auditory system
uses the alteration of the level and distribution of the GABAB receptor as a compensatory
mechanisms for rebalancing the reduction in the input from the auditory peripheral to the central
nervous system.
1.9 Research Objectives and Hypothesis
The objective of my research project was to examine changes in the level of GABAB
receptors following salicylate treatment. Specifically, I wanted to find out whether SS could
change the level of GABAB receptors in four major central auditory structures i.e. CN, IC, MG,
and AC. All these major auditory structures have a relatively high level of the GABAB receptor
and there is evidence showing an involvement of these structures in the generation of tinnitus.
CN is considered by many as a trigger centre for tinnitus (Brozoski et al., 2002; Kaltenback and
Godfrey, 2008; Shore et al., 2007). The IC is an obligatory auditory processing centre and
receives convergent ascending and descending inputs from all major auditory structures
(Anderson et al., 1980; Druga and Syka, 1984; Druga et al., 1997; Faye-Lund, 1985). MG is a
major source of input to the AC in the ascending pathway, and has major targets in the ipsilateral
AC (Winer and Schreiner, 2005). AC plays an important role in auditory sensation, perception,
and cognition (Gaese and Ostwald, 1995). I wanted to determine if salicylate-induced changes in
receptor levels had any specific cellular and/or regional localization. My hypothesis was that SS
would reduce the level of GABAB receptor subunits in all the major structures.
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2 Experimental methods
The level of the GABAB receptors in auditory structures was examined using western
blotting and immunohistochemical methods. These methods have been well established in our
laboratory and have been used to measure the expression of the GABABR1 and the GABABR2
subunits in auditory structures (Jamal et al, 2011 and 2012).
2.1 Animal Preparation
Experiments were conducted using male Wistar rats (Rattus norvegicus), weighing
between 250-350g. The rats were obtained from Charles River Laboratories Inc. (St. Constant,
QC). The animals were housed in the animal care facility at the University of Windsor for at
least one week before being used for experiments. The noise level in the animal care facility was
maintained at 55-60dB SPL. All experimental procedures were in accordance with the
guidelines of the Canadian Council on Animal Care.
2.2 Immunohistochemistry (IHC) Experiments
A pair of animals was used for each experiment, with each pair named as one case
elsewhere in the present document. In the pair, one animal was injected with physiological saline
(as control) and the other animal was injected with SS (250mg/kg). SS and physiological saline
were injected intraperitoneally (i.p.). After the injection, the animals were kept in the animal care
facility for three hours before euthanasia. I used this time frame because behavioural studies
showed that SS applied at 250mg/kg resulted in a tinnitus-like behavior with the peak effect
appearing three hours after the drug application (Jastreboff and Sasaki, 1986, 1988).
2.2.1 Tissue collection
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Animals were euthanized by an overdose of sodium pentobarbital (120mg/kg, i.p.). They
were then transcardially perfused with 200 ml of 0.1M phosphate buffer saline (PBS) and 200 ml
of 4% paraformaldehyde (PFA). The fixed brain was extracted and placed in 30% sucrose for
cryoprotection. After the brain had sunk, it was sectioned in the coronal plane at 30µm using a
CM1050 S cryostat (Leica Microsystems, Heidelberg, Germany). The sections containing
auditory structures were collected on SuperFrost Plus glass slides (Fisher Scientific, Pittsburg,
PA, USA). Sections with the same neural structures from the two animals treated with saline and
salicylate-treated were collected on the same slide besides each other. Sixteen sections were
collected for each auditory structure and were placed on 4 slides. Each slide also contained a
piece of cerebellar tissue serving as a positive control and for the purpose of normalizing the
level of immunoreactivity (see section 3.1). A set of 4 slides containing tissue from one auditory
structure was used for each IHC experiment. The arrangement of the tissue on the slide can be
seen in Figure 6.
2.2.2 IHC protocol
Slides with tissue of auditory structures were incubated overnight in the primary antibody
against the GABABR1 or GABABR2 subunit (1:1000) in 0.1M PBS containing 0.05% Triton and
5% normal donkey serum (NDS). After the incubation, the slides were rinsed with 0.1M PBS
three times, 10 minute each time, to wash away excess unbound primary antibody. The slides
were then incubated in a 0.1M PBS solution containing biotinylated secondary antibody (1:400)
and 2% NDS for 2.0 hours at room temperature. The slides were washed again with 0.1M PBS
three times, 10 minute each time, and then incubated in a solution containing ExtrAvidin-
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Figure 6. Schematic of a slide showing the mounted location of brain slices used in
immunohistochemistry experiments. SAL CB represents the cerebellum section from salinetreated animal whereas SS CB represents the cerebellum section from SS-treated animal. SAL
represents auditory slices from saline-treated animal. SS represents auditory slices from SStreated animal.
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peroxidase (E2886, 1:400) (Sigma-Aldrich, Oakville, ON, Canada) in 0.1M PBS for 1.5 hours at
room temperature. After another set of three rinses in 0.1M PBS, the tissue was stained using 3'3'
Diaminobenzidine tetrahydrochloride (DAB) in 0.1M phosphate buffer (PB). The reaction was
stopped by repeatedly pouring distilled water in and out of the keeper containing the slides. The
tissue was dehydrated by using an ethanol gradient of 60%, 70%, 95%, 100%, and 100%, 5
minutes for each ethanol concentration. The tissue was then cleared using histosol two times (10
minute each time). Permount (SP-500) (Fisher Scientific) was used to coverslip the slides. The
level of immunoreactivity was examined using bright field microscopy.
2.3 Western Blot experiments
2.3.1 Tissue collection
A pair of animals was used for each experiment and the pair was labeled as one case.
After receiving an intraperitoneal injection of either saline or sodium salicylate (250mg/kg), the
animals were given a 3 hours survival period. They were then euthanized by an overdose of
sodium pentobarbital (120mg/kg, i.p.). The brain was extracted right away and placed in chilled
artificial cerebrospinal fluid containing (in mM): 126 NaCl, 3 KCl, 1.4 KH2PO4, 26 NaHCO3, 4
glucose, 1.3 MgSO4, and 1.4 CaCl2. The brain was cut in the coronal plane into 1 mm sections,
from which tissues of the CN, IC, MG, and AC were collected using a #11 scalpel blade, a
Silgard dish, and a stereoscope (Olympus SZX7, Tokyo, Japan). “The Rat Brain in Stereotaxic
Coordinates” (Paxinos and Watson, 2007) was used as a guide during tissue collection. Tissues
of the cerebellum and the liver were also collected from the rats and used for positive and
negative control experiments. Tissues were placed in eppendorf tubes with homogenization
buffer consisting of 0.32 M sucrose in 5 mM Tris, pH 7.4. The homogenization buffer also
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contained the following protease inhibitors: 3 μM aprotinin, 10 μM phenylmethul sulfonyl
fluoride (PMSF), 1 μM leupeptin, and 3 μM pepstatin-A. This homogenization buffer was used
in all the eppendorf tubes containing collected auditory, cerebellar, and level tissues. The tubes
were kept on ice at all times. The tissue was manually homogenized using a plastic pestle, and
the homogenate was centrifuged at 3400 rpm for 20 minutes at 4°C to remove cell debris and
nuclei. The supernatant was transferred into new eppendorf tubes. The protein concentration of
each sample was determined using a Bradford Assay (Sigma-Aldrich, Oakville, ON, Canada)
and a Biomate5 spectrophotometer (Thermo Scientific, Surrey, UK).
2.3.2 Immunoblotting protocol
Thirty microgram of protein from each sample was added to 4X sample buffer and
subjected to electrophoresis using a 7.5% sodium dodecyl sulphate-polyacrylamide gel (SDSPAGE) for 2 hours at 125V. The separated proteins were transferred from the gel onto a
polyvinylidene fluoride (PVDF)-Plus 0.45 µm membrane (Osmonics Inc., Minnetonka, MN,
USA) for 2 h at 30V. The membrane was blocked with 1% milk in Tris-buffered saline tween
(TBST) for 1 hour at room temperature. The membrane was then incubated overnight at 4°C in
the primary antibody (1:1000) against the specific GABAB receptor subunit and the loading
controls. After primary antibody incubation, the membrane was rinsed in TBST three times (10
minutes each wash) to wash off excess antibody. The membrane was then incubated at room
temperature in the secondary antibody (1:6000 for GABAB receptor subunit, 1:10000 for loading
controls) for 2 hours. The membrane was rinsed in TBST for an additional three times after
secondary antibody incubation. Protein bands were detected using an enhanced
chemiluminescence (ECL) kit (Pierce, Rockford, IL, USA). Images were acquired using an HD2
gel imaging system and AlphaEase digital analysis software (Alpha Innotech, CA, USA).
46

2.4 Antibodies
The primary antibody used for GABABR1 and GABABR2 was the same for western blot
and immunohistochemical experiments. The primary antibody used against GABABR1 subunit
was rabbit polyclonal GABABR1 antiserum (Santa Cruz Biotechnology Inc, R-300, 1:1000,
Santa Cruz, CA, USA). The primary antibody used against GABABR2 was affinity purified
guinea-pig polyclonal GABABR2 antiserum (Chemicon, AB5394, 1:1000, Temecula, CA, USA).
The primary antibody used for Actin in western blot procedures was mouse monoclonal primary
antibody (Chemicon, MAB1501, 1:1000), and the primary antibody used for α-Tubulin was also
mouse monoclonal primary antibody (Chemicon, 05-829, 1:1000).
The secondary antibodies used in western blot experiments were horseradish peroxidase
(HRP)-conjugated. The secondary antibody for GABABR1 was goat anti-rabbit IgG-HRP (sc2000, 1:6000, Santa Cruz Biotechnology Inc.), and for GABABR2 was goat anti-guinea pig IgGHRP (AQ108, 1:6000, Chemicon). The secondary antibody for probing both Actin and αTubulin was anti-mouse IgG (12-349, 1:10000, Santa Cruz Biotechnology Inc.). The secondary
antibody used in immunohistochemistry experiments for GABABR1 was biotinylated donkey
anti-rabbit IgG (711-005-152, 1:400, Jackson ImmunoResearch Laboratories, Burlington, ON,
Canada), and for GABABR2 was biotinylated donkey anti-guinea pig IgG (706-065-148, 1:400,
Jackson ImmunoResearch Laboratories, Burlington, ON, Canada).
3 Data analysis
Western blots were quantified using the FluorChem 9900 imaging system
(ProteinSimple, California, USA). Densitometry values of bands for GABABR1 and GABABR2
were measured and normalized against the densitometry values of bands for α-Tubulin.
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Optic density (OD) was used to quantify the level of the GABABR1 and GABABR2
subunits following an immunohistochemical experiment. For this purpose, photomicrographic
images of issue sections containing auditory structures were taken using a CTR 6500 microscope
and a DFC 425 digital camera (Leica Microsystems, Heidelberg, Germany). Fixed settings of
light intensity and exposure were used in all photomicrographic imaging sessions. For this
purpose, a piece of tissue containing a defined cerebellar area was used at the beginning of each
imaging session for setting the intensity and exposure of the microscope light. Thus, ODs of
target areas/cells imaged in different sessions could be compared quantitatively. The images
taken by the microscope system were exported in tiff format for offline analysis.
Offline analysis of OD was conducted using the LAS V4.4 analysis software (Leica
Microsystems). In this analysis, black colour was assigned a value of 0 and white colour was
assigned a value of 255. The Rat Brain Atlas in Stereotaxic Coordinates (Paxinos and Watson,
2007) was used as a guide in defining auditory structures and their subdivisions. In four major
auditory structures (i.e., the CN, IC, MG, and AC) including all their subdivisions, the level of
labeling was analyzed for cell bodies and the neuropil in combination (i.e., the overall level), cell
bodies, and the neuropil. Since each structure was collected over a course of 16 slices, the results
from all 16 slices were combined for each structure.
For measuring the overall level of labeling, an auditory structure or a subdivision of a
structure was defined in each tissue section by using anatomical features in a microscopic image
and the Rat Brain Atlas in Stereotaxic Coordinates. The area, integrated grey (i.e., the sum of the
OD values of all pixels in the defined area), and grey mean (i.e., the mean of the OD values of all
pixels in the defined area were measured.
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For counting the number of labeled cell bodies in a target structure, an OD threshold was
set for the structure. Criteria of inclusion as well as exclusion were also set based on the size of
a cell body. For setting an OD threshold, ten small areas (5µm x 5µm) were randomly chosen in
the neuropil of the target structure. The mean OD was measured for each of the ten small areas
using ImageJ analysis software (National Institute of Health). The standard deviation of the ODs
of all pixels in the small area was also obtained. Grand mean values were obtained for both the
mean OD and the standard deviation of OD across the ten small areas to reflect the overall level
and the fluctuation of labeling in the auditory structure/subdivision. A value equalled the grand
mean OD minus 3 times of standard deviation of OD was set as a threshold OD in the
identification of cell bodies in the structure/subdivision. This ensured that only objects darker
than the neuropil by a certain level (defined by 3 times of standard deviation in OD across
different pixels in an area) were measured by the LAS software as cell bodies. A threshold was
determined for each auditory structure individually. For each pair of sections (control animal
treated with saline vs. animal treated with SS ), a threshold was determined by using the section
from the control animal. A resulting threshold value was used for tissues from both the control
animal and the SS treated animal. In addition to OD, the length of an object (i.e. the longest axis
of an object) was used to determine whether to exclude or include an object in the analysis. Only
objects with the longest axis between 6µm and 25µm were considered as cell bodies and were
measured. This criterion was the same for all the auditory structures and cases. In spite of the
criteria, the software could include non-cell body objects in the analysis or fail to include cell
bodies in the analysis. To avoid errors made by the software, human intervention was used in the
identification of cell bodies. The parameters measured by the LAS software for each identified
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cell body included: area, length, breadth, perimeter, roundness, derived orientation, integrated
grey, grey mean, and grey variance.
The mean grey value was obtained for the neuropil to reflect the level of labeling outside
cell body regions in a target structure. An integrated grey of the neuropil was obtained by
subtracting the integrated grey of a structure by the integrated grey of all the cell bodies in the
structure. The integrated grey for the neuropil was then divided by the area of the neuropil in the
structure (difference between the area of the structure and the combined area of cell bodies) to
obtain the mean grey of the neuropil.
3.1 Normalization of IHC results:
OD values obtained from auditory structures were normalized using the OD in the
molecular layer of the cerebellum (CB). Previous research has shown that the molecular layer of
cerebellum (CB) is among the neural structures showing the highest level of GABAB receptor
expression (Ige et al., 2000). No receptors are present in the white matter. Western blotting and
IHC results from the present study showed that SS did not change the level of GABAB receptors
in the CB (Figure 7). Thus, any changes seen in the CAS in SS-treated animals could be
attributed to the effect of the drug. Due to the above reasons, OD values in the molecular layer
and white matter of the CB were used as reference points and were used for normalizing the OD
values from the auditory structures. Two CB sections, one from Saline-treated animal and one
from SS-treated animal, were placed on each slide containing auditory structures. OD values
from Saline- and SS-treated animals were used for normalizing OD values of auditory structures
of corresponding animals.
Normalized OD = (ODAud - OD WM)/(OD Mol - OD WM)
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where ODAud is the OD or grey value of an auditory structure/neuron. OD WM is the OD of the
lightest area of cerebellum. OD Mol is the OD of the darkest area in molecular layer of CB. This
normalization allowed for reliable comparison of results from different structures and cases.
4 Results
4.1 The effect of SS on level of GABABR1 and GABABR2 subunit in the CB:
Western blot and IHC experiments were conducted to study the effect of SS on CB.
Neither type of experiment revealed an effect of SS on the level of GABAB subunits (Figure 7).
Shown in Figure 7a and 7b are IHC results. The OD of molecular layer of CB in slices of salinetreated animal and SS-treated animal was measured for 7 cases. For each case, 5 CB sections
were measured. OD was measured at ten randomly chosen spots from each of the 5 sections. A
mean OD was obtained by using the 50 measurements from the CB of an animal. Group results
from 7 cases indicated that the mean OD for GABABR1 receptor subunit in the CB was 37.29 for
saline-treated animals, and 36.27 for SS-treated animals (Figure 7b). No statistical difference
was found in the level of labeling between the two groups of animals. Similar experiments were
conducted to examine the effect of SS on the level of GABABR2 receptor subunit in the CB. No
statistically significant difference was found between control and SS-treated animals (date not
included). This lack of difference between the two groups of animals allowed us to use the CB as
a reference for normalizing the level of receptor subunits in auditory structures.
Shown in Figure 7c and 7d are results from wenstern blotting experiments. Bands of
immunoblots for GABABR1 receptor subunits were normalized against those of α-Tubulin
(Figure 7c). The band for CB from saline animal gave a normalized value of 2.37 whereas the
CB band from SS animal was at 2.26, indicating no significant difference (Figure
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Figure 7: Immunohistochemistry and western blot results showing the effect of SS on GABABR1
immunoreactivity in cerebellum. (A) Photomicrograph of a cerebellar section from saline-treated
animal and a cerebellar section from SS-treated animal. The molecular layer in the cerebellar
section of saline-treated animal is labeled with an "M". The granule cell layer is labeled with a
"G" and white matter is labeled with a "W". Scale bar: 500µm. (B) Bar chart for group results
from immunohistochemical experiments showing immunoreactivity against the GABABR1
subunit in the molecular layer of the cerebellum of saline-treated animal and the cerebellum of
SS-treated animal. The group results are based on analyses from seven animals treated with
saline and seven animals treated with SS. (C) Western blots showing immunoreactivity against
the GABABR1 subunit in cerebellar tissue from saline-treated animal and cerebellar tissue from
SS-treated animal. Top blot shows immunoreactivity against the two isoforms of GABABR1
subunit. The bottom blot shows α-Tubulin immunoreactivity. (D) Bar chart for group results from
western blot experiments showing immunoreactivity against the GABABR1 subunit in the
cerebellum. The ratio between the OD of the GABABR1 (including GABABR1α and GABABR1β)
band, and OD of α-Tubulin band was obtained. The group results are based on ratios from three
animals treated with saline and three animals treated with SS.
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7d). Similar results were seen for the GABABR2 receptor subunit levels in the CB (results not
shown in figure). The band for CB from one saline-treated animal and CB from one SS-treated
animal gave a normalized value of 1.04 and 1.10 respectively, indicating no significant
difference.
4.2 The effect of SS on overall levels of GABABR1 and GABABR2 subunits in auditory
structures: Western Blotting
Western blotting experiments were conducted using tissues of auditory structures from three rats
for GABABR1 subunit and tissues from one rat for GABABR2 subunit. Bands of immunoblots
for GABAB receptor subunits were normalized against those of α-Tubulin. Results revealed a
trend of reduction in the level of the GABABR1 subunit in the CN, IC, and MG 3 hours after the
intraperitoneal injection of SS (Figure 8a). The reduction in the CN was 13.6%. The reduction in
IC and MG was 26.8% and 15.5%, respectively (Figure 8b). The reduction in the level of subunit
in the AC was minimal at 7.1%. The level of the GABABR2 subunit also appeared to be reduced
by SS in all the structures (Figure 8c). The reduction was at 35.4%, 71.7%, 49.3%, and 29.8% in
the CN, IC, MG, and AC, respectively (Figure 8d).
4.3 The effect of SS on overall levels of GABABR1 and GABABR2 subunits in auditory
structures: Results based on low magnification IHC images
IHC experiments were conducted using five pairs of rats. In each pair, both subunits were
probed. Three of the five cases or pairs were analyzed for overall level of labeling, as well as cell
bodies and neuropil labeling. Low magnification images indicated that the level of the
GABABR1 subunit was decreased by SS in the CN, IC, MG, and AC (Figure 9a). For CN, IC,
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Figure 8: Western blots showing immunoreactivity against the GABABR1 and the GABABR2
subunit in the major auditory structures of saline-treated animals and SS-treated animals. A:
Western blots showing immunoreactivity against the GABABR1 subunit in the major auditory
structures. SAL represents tissue from saline treated animals. SS represents tissue from SS
treated animals. Top blots show immunoreactivity against the GABABR1α and GABABR1β
subunits. The bottom blot shows α-Tubulin immunoreactivity. B: Bar chart for group results from
western blot experiments showing immunoreactivity against the GABABR1 subunit in major
auditory structures. The ratio between the OD of the GABABR1α and GABABR1β band, and OD
of α-Tubulin band was obtained. The group results are based on ratios from three animals. Error
bars represent standard error. C: Western blots showing immunoreactivity against the
GABABR2 subunit in the major auditory structures. Top blots show immunoreactivity against the
GABABR2 subunit. The bottom blot shows α-Tubulin immunoreactivity. D: Bar chart for results
from western blot experiment showing immunoreactivity against the GABABR2 subunit in major
auditory structures. The ratio between the OD of the GABABR2 band and OD of α-Tubulin band
was obtained. The results are based on ratios from one animal.
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Figure 9A. Low magnification images showing immunoreactivity against the GABABR1 subunit
in the auditory structures. Left panel contains coronal sections from saline-treated animal. Right
panel contains coronal sections from SS-treated animal. The bottom panel contains CN (1). The
middle panel contains IC (2). The top panel contains MG(3) and AC (4).
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Figure 9B. Group results from immunohistochemical experiments showing overall (neuropil and
cell body combined) immunoreactivity against the GABABR1 subunit in major auditory
structures. The mean OD for each structure was obtained by combining the OD of all the
subdivisions in the structure. The OD was normalized against GABABR1 immunoreactivity in the
cerebellum. Results are from analyses conducted using three animals treated with saline and
three animals treated with SS.
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Figure 10A. Low magnification images showing immunoreactivity against the GABABR2
subunit in the auditory structures. Left panel contai
contains coronal sections from saline-treated
saline
animal. Right panel contains
ntains coronal sections from SS
SS-treated
treated animal. The bottom panel
contains CN (1). The middle panel contains IC (2). The top panel contains MG(3) and AC (4).

57

Figure 10B. Group results from immunohistochemical experiments showing overall (neuropil
and cell body combined) immunoreactivity against the GABABR2 subunit in major auditory
structures. The mean OD for each structure was obtained by combining the OD of all the
subdivisions in the structure. Results are from analyses conducted using three animals for
saline and three animals for SS.
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and MG, sections from SS-treated animal showed lighter labeling compared to those animals
treated with saline control. In the AC, sections from Saline and SS treated animals showed a
small difference in labeling. Overall labeling in each structure was quantified by using OD.
Resulting values were normalized against those of the molecular layer and the white matter of
the cerebellum (Figure 9b). For each structure of an individual animal, the integrated OD and the
area were measured in each section with the structure and a weighted average was obtained for
this structure. The quantified results showed a trend of reduction in all auditory structures. The
labeling in saline CN was reduced by 16% by SS. In IC, the labeling was reduced by over 31%
by SS. The labeling in the MG was reduced by close to 34% by SS. The labeling in the AC was
reduced by 11%.
For the GABABR2 subunit, low magnification images revealed a decrease in labeling in
all the auditory structures (Figure 10a). The reduction was about 11%, 24%, 23%, and 12% in
the CN, IC, MG, and AC, respectively (Figure 10b).
4.4 The effect of SS on regional and cellular distributions of GABABR1 and GABABR2 in
auditory structures: : Results based on high magnification IHC images
4.4.1 The effect of SS on the CN
4.4.1.1 The GABABR1 subunit in the CN
Regional differences exist in the level of immunoreactivity against the GABABR1
subunit in the three subdivisions of the CN. Under both saline and SS conditions, GABABR1
immunoreactivity was high in the DCN and PVCN compared to AVCN (Figure 11a,b). In both
the saline treated animal and the SS treated animal, the superficial layers of DCN and the GCD
showed highest level of immunoreactivity. In particular, the neuropil (region containing the
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axons and dendrites of cell bodies) was darkly labeled with lots of visible puncta (i.e. dark spots
or dots). In contrast, the neuropil labeling in the deep layers of DCN was light with fewer labeled
puncta, indicating lower immunoreactivity. Cell body immunoreactivity was similar across all
the layers of DCN and in GCD. Both PVCN and AVCN showed less punctate labeling in the
neuropil compared to the superficial layers of DCN and GCD. Large cell bodies resembling
globular bushy cells and octopus cells were darkly labeled in the PVCN. In the AVCN,
moderately large labeled cell bodies, presumably globular bushy cells, were darkly labeled.
There was no apparent difference in immunoreactivity across the rostral-caudal extent of the
structure.
For SS treated animals, the percentage reduction in labeling was the greatest in the
AVCN followed by PVCN. The reduction was the smallest in the DCN. Quantitative analysis
revealed that the reduction in labeling by SS was about 35% in the AVCN, 28% in the PVCN,
and 16% in the DCN (Figure 11c). The reduction was not statistically significant (p > 0.05).
High magnification images showed that the reduction in the overall level of the
GABABR1 subunit was due to changes in the level of labeling in both cell body and neuropil
regions (Figure 11a,b). The neuropil is the region outside cell bodies and it contains the axons
and dendrites of neurons. For sections from SS-treated animals, both diffused and punctate
labeling in the neuropil was reduced. In the DCN, the deep layers showed the greatest decrease
in immunolabeling amongst all the layers. Both diffused and punctate labeling was reduced in
the neuropil. In the PVCN and AVCN, diffused and punctate labeling was reduced without any
regional specificity. Cell body labeling was also equally reduced across the entire subdivision.
Quantification of the labeling in the neuropil showed that the reduction was greatest in the
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Figure 11A. Immunoreactivity to the GABABR1 subunit in the CN. Left panel contains coronal
sections from saline-treated animal. Right panel contains coronal sections from SS-treated
animal. Low magnification images show overall (neuropil and cell body combined)
immunolabeling in the DCN and PVCN. High magnification images show neuropil and cell body
labeling. White arrows point towards a labeled cell bodies. Scale bar: 200µm in low
magnification images; 50 µm in high magnification image.
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Figure 11B. Immunoreactivity to the GABABR1 subunit in the AVCN. Left panel contains
coronal sections from saline-treated animal. Right panel contains coronal sections from SStreated animal. Low magnification images show overall (neuropil and cell body in combination)
immunolabeling. High magnification images show neuropil and cell body labeling. White arrows
point towards labeled cell bodies. Scale bar: 200µm in low magnification images; 50 µm in high
magnification image.
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Figure 11C. Group results from immunohistochemical experiments showing (i) overall (neuropil
and cell body combined) and (ii) neuropil immunoreactivity against the GABABR1 subunit in the
subdivisions of CN. Analyses were conducted using three animals treated with saline and three
animals treated with SS. The OD of neuropil for each subdivision was obtained by subtracting
the combined integrated grey of all the cell bodies in a subdivision from the overall integrated
grey of the subdivision. Error bars indicate standard error.
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Figure 11D. (i) Bar chart showing the total number of GABABR1 immunoreactive cell bodies in
each subdivision of CN. Error bars indicate standard error. (ii-iv) Histograms showing cgroup
results for normalized OD distribution of GABABR1 immunoreactive cell bodies in the
subdivisions of CN. Results are from analyses conducted using three animals treated with
saline and three animals treated with SS.
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AVCN (33%), followed by PVCN (27%) and then DCN (15%) (Figure 11c). The reduction was
not statistically significant (p > 0.05).
SS also caused a decrease in the labeling in cell bodies in all three subdivisions (Figure
11d, i, ii, iii). The decrease was reflected in the ODs of labeled cell bodies and the total number
of labeled cell bodies. As indicated in Figure 11d (i), (ii), (iii), the distribution of the OD values
of labeled cell bodies in SS-treated animals was shifted leftward in comparison to that in salinetreated animals. For both animals treated with saline and SS, the total number of labeled cell
bodies was highest in DCN, followed by PVCN and AVCN (Figure 11d). The cell bodies
seemed more densely packed in the DCN than in the other two subdivisions. The SS-induced
decrease in the number of labeled cell bodies was highest in the DCN, followed by AVCN, and
then PVCN. The reduction in the number of labeled cell bodies was about 74% in the DCN, 71%
in the AVCN, and about 68% in the PVCN. This reduction in cell body number was statistically
significant (p < 0.0001).
4.4.1.2 The GABABR2 subunit in the CN
For both animals treated with saline and SS, DCN and PVCN showed the highest overall
immunoreactivity, followed AVCN (Figure 12a, b). Similar to the GABABR1 subunit
distribution, the GABABR2 immunoreactivity was the highest in the superficial layers of the
DCN and GCD compared to the deep layers. Both diffused and punctate labeling was relatively
high in the superficial layers. Cell body labeling was similar across all the layers of the DCN and
in the GCD. PVCN and AVCN had lower levels of diffused and punctate labeling compared to
the DCN. There were no regional differences in neuropil labeling or cell body labeling between
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PVCN and AVCN. Qualitative observations revealed that the CN subdivisions were similar in
labeling across the rostral-caudal extent of the structure.
After treatment with SS, there was a trend of reduction in the overall level of the
GABABR2 subunit in all the three subdivisions of the CN (Figure 12a,b). The reduction in the
overall level of labeling was the highest in the PVCN at 22% (Figure 12c). DCN showed an
intermediate reduction at 11%, and AVCN showed the smallest reduction at 7%. This reduction
was not statistically significant (p > 0.05).
High magnification images showed that both diffused and punctate labeling was reduced
in the neuropil of CN in sections of SS treated animals (Figure 12a,b). This reduction was greater
in the deep layers of DCN than the superficial layers. The reduction in neuropil immunolabeling
was similar across the entire PVCN and AVCN. OD values revealed that SS-induced decrease in
neuropil immunoreactivity was the greatest in the PVCN (22%). DCN and AVCN showed
smaller decreases, at 10% and 8% respectively (Figure 12c). The reduction was not statistically
significant (p > 0.05).
High magnification images showed that for all three subdivisions there weren't large
differences in the optic density of labeled cell bodies between saline- and SS-treated animals
(Figure 12a,b). The cell bodies appeared equally dark in all subdivisions for animals in both
groups. However, SS-treatment resulted in a reduction in the number of labeled cell bodies
(Figure 12d). Similar to GABABR1, the number of GABABR2-immunoreactive cell bodies was
the highest in the DCN, followed by PVCN and AVCN. The percentage reduction in the number
of cell bodies was the highest in AVCN, followed by PVCN, and then DCN. Qualitative
examination revealed that in the DCN, the decrease was greatest in the deep layers. The
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Figure 12A: Immunoreactivity to the GABABR2 subunit in the CN. Left panel contains coronal
sections from saline-treated animal. Right panel contains coronal sections from SS-treated
animal. Low magnification images show overall (neuropil and cell body combined)
immunolabeling in the DCN and PVCN. High magnification images show neuropil and cell body
labeling in the DCN and PVCN. White arrows point towards a labeled cell body. Scale bar:
200µm in low magnification images; 50 µm in high magnification image.
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Figure 12B: Immunoreactivity to the GABABR2 subunit in the AVCN. Left panel contains
coronal sections from saline-treated animal. Right panel contains coronal sections from SStreated animal. Low magnification images show overall (neuropil and cell body in combination)
immunolabeling. High magnification images show neuropil and cell body labeling. White arrows
point towards a labeled cell body. Scale bar: 200µm in low magnification images; 50 µm in high
magnification image.
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Figure 12C: Group results from immunohistochemical experiments showing (i) overall (neuropil
and cell body in combination) and (ii) neuropil immunoreactivity against the GABABR2 subunit in
the subdivisions of the CN. Analyses were conducted using three animals for saline and three
animals for SS. The OD of neuropil was obtained by subtracting the combined integrated grey of
all the cell bodies in a subdivision from the overall integrated grey of the subdivision. Error bars
indicate standard error.
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Figure 12D: (i) Bar chart showing the total number of GABABR2 immunoreactive cell bodies in
each subdivision. (ii-iv) Histograms showing group results for normalized OD distribution of
GABABR2 immunoreactive cell bodies in the subdivisions of CN. Results are from analyses
conducted using three animals for saline and three animals for SS.
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percentage reduction in the number of labeled cell bodies in the AVCN of SS-treated animals
was 44%. The percentage reduction in the number of labeled cell bodies in the PVCN and DCN
of SS-treated animals was at 47% and 74% respectively. The reduction in number of labeled cell
bodies was statistically significant (p < 0.0001). The labeling in cell bodies was also reduced, as
indicated by the leftward shift of the distribution of the OD values of labeled cell bodies in SStreated animals in comparison to that in saline-treated animals.
4.4.2 The effect of SS on the IC
4.4.2.1 The GABABR1 subunit in the IC
Low magnification images showed that there were differences in the overall
immunoreactivity against the GABABR1 subunit among the three subdivisions of the IC (Figure
13a). For both sections from animals treated with saline and SS, ICd had the highest level of
labeling, followed by ICc and ICx. The neuropil in the ICd had a high level of diffused and
punctate labeling. The immunolabeling gradually reduced going from dorsal to medial side of the
ICd. ICx had a moderate level of diffused and punctate labeling. The labeling on the medial side
of the ICx was somewhat lighter than the lateral side of the structure. ICc had low levels of
diffused and punctate labeling. The labeling was darker along the borders with ICd and ICx and
gradually reduced along the dorsoventral-ventromedial axis. The cell body labeling was high in
the ICd and ICx. In the ICc, the cell bodies were only slightly lighter. There were differences in
overall labeling amongst the subdivisions of the IC across the rostral-caudal extent, with the
caudal slices showing higher immunoreactivity in each subdivision.
A treatment with SS resulted in a decrease in the overall level of labeling in all three
subdivisions (Figure 13b). The percentage reduction was the greatest in the ICc (a 47%
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reduction), followed by the ICx (a 36% reduction) and ICd (a 31% reduction). The reduction was
similar across the rostral-caudal extent of the structure, and was not statistically significant (p >
0.05).
High magnification images showed that the decrease in the immunoreactivity against the
GABABR1 antibody occurred in both the neuropil and cell bodies (Figure 13a). The neuropil of
the IC showed a gradient of labeling, with the ICd showing the highest level of
immunoreactivity, followed by ICc and ICx. In the neuropil of all the IC subdivisions of saline
treated animals, there was a high level of punctate labeling. Both diffused and punctate labeling
was greatly reduced in all IC subdivisions of SS treated animals. Quantitative results revealed
that the immunoreactivity against GABABR1 in the neuropil was reduced by 46% in the ICc, by
34% in the ICx, and by 30% in the ICd (Figure 13b). The reduction was not statistically
significant (p > 0.05).
Differences in cell body labeling were also observed in all the subdivisions of the IC
between saline and SS treated animals (Figure 13c). Cell bodies in sections from saline-treated
animals were darker compared those in sections from SS-treated animals (Figure 13a). There
were fewer labeled cell bodies in the IC of SS-treated animals compared to that in the same
structure of saline-treated animals. The total number of labeled cell bodies was highest in the
ICx, followed by ICc and ICd in both saline and SS. The reduction in the number of labeled cell
bodies was highest in the ICc at 96%, intermediate in ICx at 81%, and lowest in ICd at 70%
(Figure 13c). The decrease in number of labeled cell bodies was statistically significant (p <
0.0001). Histograms of OD values of cell bodies indicated that the cell body labeling was
decreased after treatment with SS, indicated by a leftward shift of the distribution.
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Figure 13A: Immunoreactivity to the GABABR1 subunit in the IC. Left panel contains coronal
sections from saline-treated animal. Right panel contains coronal sections from SS-treated
animal. Low magnification images show overall (neuropil and cell body combined)
immunolabeling in the IC. High magnification images show neuropil and cell body labeling in the
ICd, ICx, and ICc. White arrows point towards a labeled cell body. Scale bar: 200µm in low
magnification images; 50 µm in high magnification image.
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Figure 13B: Group results from immunohistochemical experiments showing (i) overall (neuropil
and cell body combined) and (ii) neuropil immunoreactivity against the GABABR1 subunit in the
subdivisions of the IC. Analyses were conducted using three animals for saline and three
animals for SS. The OD of neuropil was obtained by subtracting the combined integrated grey of
all the cell bodies in a subdivision from the overall integrated grey of the subdivision. Error bars
indicate standard error.
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Figure 13C: (i) Bar chart showing the total number of GABABR1 immunoreactive cell bodies in
each subdivision of the IC. (ii-iv) Histograms showing group results for normalized OD
distribution of GABABR1 immunoreactive cell bodies in the subdivisions of IC. Results are from
analyses conducted using three animals for saline and three animals for SS.
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4.4.2.2 The GABABR2 subunit in the IC
For both sections from animals treated with saline and SS, ICd showed the highest level
of immunoreactivity against the GABABR2 among the three subdivisions. Both diffused and
punctate labeling was high in ICd (Figure 14a). There was a gradient of labeling with the
immunolabeling decreasing going from dorsal to the ventral part of ICd. The level of
immunolabeling was moderate in the ICx. Diffused labeling was lighter compared to ICd and
there was less punctate labeling. There was a reduction in the level of immunolabeling along an
axis, from the lateral to the medial part of ICx. ICd and ICx also had darkly labeled cell bodies
packed close together, indicating high cell packing density. The level of immunoreactivity was
low in the ICc for both diffused and punctate labeling. The labeling was darker along the borders
with ICd and ICx. There were also differences in labeling along the rostral-caudal extent of the
IC with the caudal slices showing higher immunolabeling.
Differences were observed in the IC in overall immunoreactivity against the GABABR2
subunit between saline and SS-treated animals. SS-induced reduction in overall level of
immunoreactivity was similar among the three subdivisions of the IC (28%, 27%, and 24% in the
ICc, ICx, and ICd, respectively) (Figure 14b).
High magnification images showed that a reduction in the immunoreactivity against the
GABABR2 receptor subunit existed in both neuropil and cell body regions (Figure 14a). For
tissues from SS-treated animals, diffused and punctate labeling in the neuropil was reduced in all
the subdivisions. The level of reduction was similar across the three collicular subdivisions (28%
in the ICc, 26% in the ICx, and 23% in the ICd) (Figure 14b). This reduction was not statistically
significant (p > 0.05).
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Differences also existed in cell body labeling between tissues from control animals and
SS-treated animals (Figure 14a). The total number of labeled cell bodies in each subdivision also
decreased after SS-treatment. Quantitative results revealed that the ICc had an 83% reduction in
the number of labeled cell bodies, which was the highest among those in the three subdivisions
(Figure 14c). The reduction in the number of labeled cell bodies was 73% in the ICx and 62% in
the ICd. This decrease was statistically significant (p < 0.0001). In addition to the reduction in
the number of labeled cell bodies, the ODs of labeled cell bodies also decreased after SS
treatment. This decrease was observed in all the three subdivisions of the IC, as indicated by the
leftward shift of the histogram of OD values (Figure 14c).
4.4.3 The effect of SS on the MG
4.4.3.1 The GABABR1 subunit in the MG
For both saline and SS treated animals, all subdivisions showed the similar levels of
immunoreactivity against the GABABR1subunit. The neuropil of the MG showed a high level of
punctate labeling along with diffused labeling. Cell body labeling was similar across the three
subdivisions of the MG. The labeling was also similar across the rostral-caudal extent of the MG
as indicated by qualitative examination of tissue.
The overall level of immunoreactivity was different between animals treated with saline
and SS. Low magnification images showed that SS reduced the overall level of immunoreactivity
in all three subdivisions (Figure 15a). The MGm showed the greatest percentage reduction
among the three subdivisions (Figure 15b). The percentage reduction was 47%, 42%, and 36%
respectively in the MGm, MGv, and MGd, respectively. This reduction was not statistically
significant (p > 0.05), and was similar across the rostral-caudal extent of the MG.
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Figure 14A: Immunoreactivity to the GABABR2 subunit in the IC. Left panel contains coronal
sections from saline-treated animal. Right panel contains coronal sections from SS-treated
animal. Low magnification images show overall (neuropil and cell body combined)
immunolabeling in the IC. High magnification images show neuropil and cell body labeling in the
ICd, ICx, and ICc. White arrows point towards a labeled cell body. Scale bar: 200µm in low
magnification images; 50 µm in high magnification image.
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Figure 14B: Group results from immunohistochemical experiments showing (i) overall (neuropil
and cell body combined) and (ii) neuropil immunoreactivity against the GABABR2 subunit in the
subdivisions of the IC. Analyses were conducted using three animals for saline and three
animals for SS. The OD of neuropil was obtained by subtracting the combined integrated grey of
all the cell bodies in a subdivision from the overall integrated grey of the subdivision. Error bars
indicate standard error.
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Figure 14C: (i) Bar chart showing the total number of GABABR2 immunoreactive cell bodies in
each subdivision of the IC. (ii-iv) Histograms showing group results for normalized OD
distribution of GABABR2 immunoreactive cell bodies in the subdivisions of IC. Results are from
analyses conducted using three animals for saline and three animals for SS
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High magnification images showed that SS reduced the level of immunoreactivity against
the GABABR1 in both the neuropil and cell body regions (Figure 15a). After SS treatment, the
diffused and punctate labeling in the neuropil was reduced in all the subdivisions. This reduction
was the greatest in MGm (46% decrease), followed by the MGv (a 40% decrease) and MGd (a
34% decrease) (Figure 15b). The reduction was similar across the rostral-caudal extent of the
structure. However, this reduction was not statistically significant (p > 0.05).
High magnification images showed that after treatment with SS, there was reduction in
the number of labeled cell bodies (Figure 15a). Cell bodies in sections from saline treated
animals were darkly labelled in all the subdivisions of MG. After SS-treatment, the ODs of cell
bodies in all the subdivisions of MG in SS-treated animals were not significantly changed.
Quantitative results showed that there was a decrease in the total number of labeled cell bodies
after SS treatment (Figure 15c). The reduction was the greatest in the MGm (an 89% reduction),
followed by the MGv (an 80% decrease) and MGd (a 67% decrease). This reduction was
statistically significant (p < 0.0001). Histograms of cell body labeling indicated that the labeling
in cell bodies was not different (Figure 15c). The distributions of labeling in cell bodies for
saline-treated animals and SS-treated animals was the same.
4.4.3.2 The GABABR2 subunit in the MG
For saline-treated animals, there were no differences in the overall level of labeling
amongst the three subdivisions of the MG (Figure 16a). Neuropil and cell body labeling was
similar across all three subdivisions. Qualitative examination of tissue revealed that there were
no differences in labeling across the rostral-caudal extent of the structure.
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Figure 15A: Immunoreactivity to the GABABR1 subunit in the MG. Left panel contains coronal
sections from saline-treated animal. Right panel contains coronal sections from SS-treated
animal. Low magnification images show overall (neuropil and cell body in combination)
immunolabeling in the MG. High magnification images show neuropil and cell body labeling in
the MGd, MGv, and MGm. White arrows point towards a labeled cell body. Scale bar: 200µm in
low magnification images; 50 µm in high magnification image.
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Figure 15B: Group results from immunohistochemical experiments showing (i) overall (neuropil
and cell body combined) and (ii) neuropil immunoreactivity against the GABABR1 subunit in the
subdivisions of the MG. Analyses were conducted using three animals for saline and three
animals for SS. The OD of neuropil was obtained by subtracting the combined integrated grey of
all the cell bodies in a subdivision from the overall integrated grey of the subdivision. Error bars
indicate standard error.
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Figure 15C: (i) Bar chart showing the total number of GABABR1 immunoreactive cell bodies in
each subdivision of the MG. (ii-iv) Histograms showing group results for normalized OD
distribution of GABABR1 immunoreactive cell bodies in the subdivisions of MG. Results are from
analyses conducted using three animals for saline and three animals for SS.
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After treatment with SS, the MGd and MGv showed similar levels of reduction. The
MGm was less darkly labeled compared to MGd and MGv in SS-treated animals. Low
magnification images showed a decrease in the overall immunoreactivity against the GABABR2
subunit after SS treatment (Figure 16a). The MG of SS treated animals was lighter in labeling
compared to the MG of saline-treated animals. The reduction in the overall level of labeling was
highest in MGm (31%), followed by MGd (22%) and MGv (22%) (Figure 16b). This reduction
was not statistically significant (p > 0.05).
There were not big differences in the level of labeling in the neuropil among different
MG subdivisions for saline treated animals. While the neuropil in the MGd and MGv was
equally dark, that in the MGm was slightly lighter. There was a lot of punctate labeling in the
neuropil across the MGd and MGv, and moderate level of punctate labeling in the MGm. High
magnification images showed that after SS treatment, the reduction in immunoreactivity against
the GABABR2 existed in both the neuropil and cell bodies (Figure 16a). The neuropil of all the
three MG subdivisions was lighter with reduced diffused and punctate labeling in animals treated
with SS. The reduction in immunoreactivity in the neuropil was 29% in the MGm, 21% in the
MGd, and 21% in the MGv (Figure 16b). This reduction was not statistically significant (p >
0.05).
The level of labeling in cell bodies was different between animals treated with saline and
SS (Figure 16a). For the MG of saline treated animals, there were no differences in cell packing
density amongst the three subdivisions. Cell bodies on all the subdivisions appeared equally
dark. In contrast, there were very few labeled cell bodies after SS treatment. Quantitative results
showed that MGm had the highest decrease in the number of labeled cell bodies (Figure 16c). It
showed a 79% decrease. MGd showed a 66% decrease and MGv showed a 65% decrease. This
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Figure 16A: Immunoreactivity to the GABABR2 subunit in the MG. Left panel contains coronal
sections from saline-treated animal. Right panel contains coronal sections from SS-treated
animal. Low magnification images show overall (neuropil and cell body in combination)
immunolabeling in the MG. High magnification images show neuropil and cell body labeling in
the MGd, MGv, and MGm. White arrows point towards a labeled cell body. Scale bar: 200µm in
low magnification images; 50 µm in high magnification image.
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Figure 16B: Group results from immunohistochemical experiments showing (i) overall (neuropil
and cell body combined) and (ii) neuropil immunoreactivity against the GABABR2 subunit in the
subdivisions of MG. Analyses were conducted using three animals for saline and three animals
for SS. The OD of neuropil was obtained by subtracting the combined integrated grey of all the
cell bodies in a subdivision from the overall integrated grey of the subdivision. Error bars
indicate standard error.
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Figure 16C: (i) Bar chart showing the total number of GABABR2 immunoreactive cell bodies in
each subdivision of the MG. (ii-iv) Histograms showing group results for normalized OD
distribution of GABABR2 immunoreactive cell bodies in the subdivisions of MG. Results are from
analyses conducted using three animals for saline and three animals for SS.
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decrease was statistically significant (p < 0.0001). The distributions of labeling in cell bodies for
saline-treated animals and SS-treated animals was the same, indicating equally dark cell body
labeling.
4.4.4 The effect of SS on the AC
4.4.4.1 The GABABR1 subunit in the AC
There was a small difference in immunoreactivity against GABABR1subunit between the
AC of saline and SS treated animals (Figure 17a). For saline treated animals, there were no
differences in labeling between the three subdivisions of AC i.e. AU1, AUD, and AUV. All three
subdivisions showed a high level of diffused and punctate labeling. The cell bodies were also
equally dark amongst the three subdivisions. Qualitative examination revealed that there were
differences in labeling across the six layers of the AC. The most superficial layers i.e. Layers IIII showed darker diffused and punctate immunolabeling compared to the deep layers i.e. layers
IV-VI. There were more labeled puncta in layers II and III compared to layer I. Layers IV and V
diaplayed intermediate diffused labeling with fewer labeled puncta whereas layer VI has the
lowest level of diffused labeling with very few puncta.
Qualitative examination of the layers showed that cell body labeling and packing density
varied between the six layers. Layer I had few darkly labeled cell bodies interspersed between
the neuropil. Layers II and III had a large number of darkly labeled pyramidal and non-pyramidal
neurons. These neurons were tightly packed together, indicating high cell packing density.
Layers IV and V had large pyramidal neurons which were darkly labeled. Labeled fibers running
from the medial to the lateral extent of the AC were also seen in these layers. Layer VI had a
large number of small pyramidal neurons packed close together, indicating high cell packing
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density. However, the cell bodies were lighter in labeling compared to the cell bodies in the other
five layers. There were no differences in neuropil or cell body labeling in the AC subdivisions
and amongst the layers across the rostral-caudal extent of the structure.
Low magnification images showed that after treatment with SS, there was a trend of
decrease in the overall immunoreactivity across all the subdivisions of AC and across all the
layers. The reduction in the overall level of labeling was highest in AUV (15%), followed by
AUD (13%) and AU1 (11%) (Figure 17b). This reduction was not statistically significant (p >
0.05).
There was no difference in neuropil labeling amongst the three AC subdivisions in saline
treated animal (Figure 17a). All three subdivisions displayed a high level of diffused and
punctate labeling. High magnification images showed that after treatment with SS, a small
reduction in GABABR1 immunoreactivity existed in the neuropil and cell bodies across the three
subdivisions. The neuropil of SS treated animals showed a decrease in diffused and punctate
labeling across all three subdivisions. The reduction in immunoreactivity in the neuropil was
14% in the AUV, 13% in the AUD, and 11% in the AU1 (Figure 17b). This reduction was not
statistically significant (p > 0.05).
Diffused and punctate labeling was decreased across all the layers of the AC, with the
largest decrease observed in layer VI. Layer IV and IV showed intermediate decrease in neuropil
labeling and layers I-III showed the smallest decrease. This decrease in labeling was observed
qualitatively.
There was a difference in cell body labeling between animals treated with saline and
animals treated with SS (Figure 17a). The AC of saline treated animals showed no difference in
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Figure 17A: Immunoreactivity to the GABABR1 subunit in the AC. Left panel contains coronal
sections from saline-treated animal. Right panel contains coronal sections from SS-treated
animal. Low magnification images show overall (neuropil and cell body in combination)
immunolabeling in the AC. High magnification images show neuropil and cell body labeling in
the AU1, AUD, and AUV. White arrows point towards a labeled cell body. Scale bar: 200µm in
low magnification images; 50 µm in high magnification image.
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Figure 17B: Group results from immunohistochemical experiments showing (i) overall (neuropil
and cell body combined) and (ii) neuropil immunoreactivity against the GABABR1 subunit in the
subdivisions of the AC. Analyses were conducted using three animals for saline and three
animals for SS. The OD of neuropil was obtained by subtracting the combined integrated grey of
all the cell bodies in a subdivision from the overall integrated grey of the subdivision. Error bars
indicate standard error.
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Figure 17C: (i) Bar chart showing the total number of GABABR1 immunoreactive cell bodies in
each subdivision of the AC. (ii-iv) Histograms showing group results for normalized OD
distribution of GABABR1 immunoreactive cell bodies in the subdivisions of AC. Results are from
analyses conducted using three animals for saline and three animals for SS.
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cell packing density or cell body labeling amongst the three subdivisions. After SS treatment, the
number of labeled cell bodies decreased (Figure 17c). The decrease was similar across the three
subdivisions with 54% decrease in the AU1, 51% decrease in the AUD, and a 50% decrease in
the AUV. This decrease was statistically significant (p < 0.0001). The distribution of the OD of
cell bodies revealed no significant difference in the labeling between the saline-treated animals
and SS-treated animals.
Qualitative observation of cell body labeling and packing density in the layers of AC
revealed a decrease in the number of labeled cell bodies and in cell body labeling in all the
layers. The largest decrease was seen in layer VI, followed by layer IV, layers I-III, and layer V.
4.4.4.2 The GABABR2 subunit in the AC
Similar to the GABABR1 subunit, the GABABR2 subunit immunoreactivity was
decreased in the AC after SS treatment (Figure 18a). There were no differences in labeling
among the three subdivisions of AC in the saline treated animal. The level of diffused and
punctate labeling was high in all the subdivisions. There were immunolabeling differences
among the six layers, with layers I-III showing the highest level of diffused and punctate
labeling, followed by layers IV and V which showed intermediate level. Layer VI had the lowest
level of diffused and punctate immunolabeling amongst the six layers. Cell body labeling and
packing density for GABABR2 subunit immunoreactive cell bodies was similar to GABABR1
subunit immunoreactive cell bodies. Layers I-III had darkly labeled, densely packed, small
pyramidal and non-pyramidal neurons. Layers IV and V had large pyramidal neurons which
were darkly labeled. The cell packing density in layers IV and V was low compared to that in
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layers I-III. Layer VI had small neurons which were densely packed, but they were lighter in
labeling compared to neurons in the other layers.
The labeling was decreased across all three subdivisions after SS treatment. The
reduction in immunoreactivity was highest in the AUV (14%, followed by AUD (13%) and AU1
(12%) (Figure 18b). This reduction was not statistically significant (p > 0.05).
Qualitative observations revealed that there were differences in immunoreactivity
reduction among the six layers after treatment with SS. Layer VI showed the largest decrease in
labeling, followed by layers IV and V, and layers I-III.
The neuropil of AC in saline treated animal was similarly labeled (Figure 18a). Each
subdivision showed a high level of diffused and punctate labeling. The level of diffused and
punctate labeling was decreased after SS treatment. This decrease was similar across the three
subdivisions with AUV and AUD at 13% each. AU1 showed a 12% reduction in neuropil
labeling (Figure 18b). This reduction was not statistically significant (p > 0.05).
Qualitative observations revealed that there were differences in reduction in the neuropil
among the six layers after treatment with SS. Layer VI showed the largest decrease in labeling,
for both diffused and punctate labeling, followed by layers IV and V, and layers I-III.
Cell body labeling in the AC was different between saline treated animal's AC and SS
treated animal's AC (Figure 18a). The AC of saline treated animal showed no differences in cell
packing density or cell body labeling among the three subdivisions. The cell bodies were densely
packed and equally dark. After SS treatment, the number of labeled cell bodies decreased across
all three subdivisions (Figure 18c). The reduction in labeled cell bodies was highest in the AU1
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(68%). AUD showed a 66% reduction in the number of labeled cell bodies whereas AUV
showed a 61% reduction. This reduction was statistically significant (p < 0.0001).
There were differences in cell body labeling among the layers after SS treatment. Layer
VI showed the largest decrease in the number of labeled cell bodies, as well as labeling in the
cell bodies, followed by layers I-III, layer IV, and layer V.
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Figure 18A: Immunoreactivity to the GABABR2 subunit in the AC. Left panel contains coronal
sections from saline-treated animal. Right panel contains coronal sections from SS-treated
animal. Low magnification images show overall (neuropil and cell body combined)
immunolabeling in the AC. High magnification images show neuropil and cell body labeling in
the AU1, AUD, and AUV. White arrows point towards a labeled cell body. Scale bar: 200µm in
low magnification images; 50 µm in high magnification image.
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Figure 18B: Group results from immunohistochemical experiments showing (i) overall (neuropil
and cell body in combination) and (ii) neuropil immunoreactivity against the GABABR2 subunit in
the subdivisions of the AC. Analyses were conducted using three animals for saline and three
animals for SS. The OD of neuropil was obtained by subtracting the combined integrated grey of
all the cell bodies in a subdivision from the overall integrated grey of the subdivision. Error bars
indicate standard error.
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Figure 18C: (i) Bar chart showing the total number of GABABR2 immunoreactive cell bodies in
each subdivision of the AC. (ii-iv) Histograms showing group results for normalized OD
distribution of GABABR2 immunoreactive cell bodies in the subdivisions of AC. Results are from
analyses conducted using three animals for saline and three animals for SS.
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Figure 19: Bar charts showing neuropil immunoreactivity against the GABABR1 and GABABR2
subunits in the major auditory structures. Analyses were conducted using three animals for
saline and three animals for SS. The OD of neuropil was obtained by combining the weighted
averages of neuropil OD from each subdivision in a structure.
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Figure 20: Bar charts showing the total number of GABABR1 and GABABR2 immunoreactive
cell bodies in the major auditory structures. Analyses were conducted using three animals for
saline and three animals for SS. The number of immunoreactive cell bodies in the subdivisions
was combined to obtain the total cell body number for each structure.
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5 Discussion
Results from present research indicated that intraperitoneal injection of sodium salicylate
reduced the protein levels of the GABABR1 and GABABR2 receptor subunits in the four major
auditory structures (i.e., the CN, IC, MG, and AC) 3 hours after the drug application. The
change, presented as a percent difference between SS and saline, was the greatest in the IC and
MG, intermediate in the CN, and minor in the AC. In the IC, MG, and CN, area differences exist
in the degree of reduction among different subdivisions. The reduction in the level of receptor
subunits was observed in both cell body (as revealed by the number of labelled cell bodies and
the optic density reflecting the strength of immunoreactivity in a cell body) and the neuropil
areas. Between the two receptor subunits, degrees of reduction were generally parallel across
different auditory structures.
5.1 The relationship between a reduction in the level of the GABAB receptor and SSinduced tinnitus
SS-induced tinnitus is accompanied by changes in the neural activity in the central
auditory system (Berliner et al., 1992; Barrs and Brackman, 1984; House and Brackman, 1981;
Kaltenbach et al., 2005). Previous neurophysiological/neuropharmacological experiments have
indicated that SS can directly affect neurotransmitter receptors and ion channels (Basta et al.
2000, 2008; Basta and Ernst, 2004). There was evidence showing that the drug could change the
level of certain neurotransmitter receptors in the CAS (Bauer et al., 2000). The current study
provides a direct evidence showing that SS can change the level of the GABAB receptor in the
CAS. Along with the effect of the drug on other neurotransmitter receptors, the drug effect on the
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GABAB receptor can affect the balance between excitation and inhibition. This may
consequently affect the level of neural activity in the CAS.
In contrast to a reduction in the output from the cochlea, there is an enhancement in
neural activity in the AC after SS application (Sun et al., 2009). This difference suggest that the
“gain” was enhanced in signal transmission along the ascending auditory pathway. It was
unknown which auditory structure contributed to this increase in the gain. Results from the
present study show that the level of the GABAB receptor was reduced in all the four major
auditory structures. This reduction can very likely cause a reduction in inhibition in every of the
four structures, suggesting that there is no single origin of SS-induced tinnitus. The activity in
each auditory structure can be compromised due to decreased GABAB receptor subunit levels.
This suggests that all the four structures may contribute to the increase in the gain, leading to
hyperactivity in neurons in the AC.
All the major auditory structures are connected to each other, forming a neural circuit. An
reduction in the level of the GABAB receptor and subsequent enhancement in neural activity in
each of the structures can lead to a change in the way how a neural circuit works. It’s very likely
that such an increase in the level of activity in all the components of a network can lead to
synchronized activation/resonance in the network and an epileptic form of physiological
responses. These types of physiological responses may be responsible for the sensation of
hyperacusis and tinnitus.
5.2 Change in GABABR1 and GABABR2 receptor levels in the CN
Results from the present study showed that intraperitoneal injection of a single dose of SS
at the dosage of 250 mg/kg caused a decrease in the level of GABABR1 and GABABR2 receptor
103

subunits in the CN 3 hours after the drug application. This change was seen in all the
subdivisions of the CN. CN is considered the trigger centre of tinnitus with many studies
reporting hyperactivity in the DCN after SS treatment (Brozoski et al., 2002; Kaltenbach and
Godfrey, 2008; Shore et al., 2007). Not many studies have been conducted on the VCN. Holt et
al., (2010) used manganese enhanced-MRI to image neural activity after chronic SS treatment
and found an increase in activity in the DCN but no change in the VCN. Wallhauser-Franke et
al., (2003) also reported increase in DCN activity after chronic SS treatment but no change in the
VCN. My results show a larger reduction in the GABAB subunit levels in the VCN subdivisions
than in the DCN, indicating a greater decrease in inhibition in the VCN. This should translate to
hyperactivity in the VCN. This difference in results might be due to a difference in experimental
procedures. Holt and colleagues, and Wallhauser-Franke and colleagues used chronic SStreatment whereas I used acute SS treatment. It is possible that in the case of chronic treatment,
the nervous system was able to homeostatically regulate inhibition in the VCN but not in the
DCN, resulting in persistent hyperactivity in the DCN which was measured.
VCN has low levels of GABAB receptor (Juiz et al., 1994). However, studies using
neurochemicals have shown the entire VCN to contain numerous GAD and GABA
immunoreactive endings and cell bodies (Godfrey et al., 1977, 1978, 1988). The majority of
these GABA immunoreactive endings and cell bodies most likely contain GABAA receptors
since GABAA receptors outnumber GABAB receptors in the CN. The levels of GABAA receptors
in the VCN are amongst the highest in the brain (Chu et al., 1990). GABAB receptors regulate
the release of GABA which could activate GABAA receptors, so a decrease in GABAB receptors
could lead to a dysregulation of inhibitory activity in the VCN. GABAB receptors also regulate
the release of glutamate, the excitatory neurotransmitter and regulate excitatory activity. It is
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possible that in the VCN, reduction in GABAB receptor levels affects the excitatory and
inhibitory neurotransmission in a similar way so that the net effect is either an insignificant
change or no change in neural activity.
Studies using neurochemicals have shown that the superficial layers of DCN contains
numerous GAD and GABA immunoreactive endings and cell bodies (Godfrey et al., 1977, 1978,
1988). Both GABAA and GABAB receptors are present in the DCN. GABAA receptors are
present at high levels in all the layers of DCN whereas the molecular layer of DCN has the
highest level of GABAB receptors in the entire CN (Juiz et al., 1994). The GABAB receptors in
DCN might be more involved in regulation of inhibition than excitation. Therefore, the decrease
in GABAB receptor levels in the DCN after SS treatment might cause a greater decrease in
inhibition, leading to hyperactivity in the structure.
DCN receives projections from ANFs and projects to the IC and MG (Schofield and
Coomes. 2005). It is an important structure in auditory processing, and has been shown to play a
role in suppressing sounds generated by movement or self-vocalization (Kanold et al., 2011;
Keohler et al., 2011). A disruption of neural activity in the DCN can not only interfere with its
roles in sound suppression but these disruptions can be transmitted to IC and MG, leading to
improper auditory processing, and tinnitus.
5.3 Changes in GABABR1 and GABABR2 receptor levels in the IC
Of the four central auditory structures analyzed, IC showed the greatest change in
receptor subunit levels after SS treatment. This is in agreement with neuroimaging results which
reported greater levels of hyperactivity in the IC compared to other auditory structures after
chronic SS treatment (Holt et al., 2010). The increase in activity was attributed to a decrease in
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inhibition. Many studies using systemic SS application have found a decrease in GABAergic
inhibition after SS application (Bauer et al., 2000; Zou and Shang, 2012). My results show that
the decrease in GABAergic inhibition in IC might partially be due to a decrease in GABAB
receptor levels.
Among the three subdivisions of the IC, ICc had the highest reduction in GABAB subunit
levels followed by ICx and then ICd. Chronic SS application studies have reported the greatest
increase in activity in the ICd followed by ICc and then ICx (Holt et al., 2010, WallhauserFranke et al., 2003). The difference between their results and mine might be due to several
reasons. Firstly, Holt and colleagues as well as Wallhauser-Franke and colleagues used chronic
SS treatment, whereas I used acute SS treatment. Secondly, the difference in receptor subunit
levels reported in this study is a percentage difference. It is measured relative to the labeling in
each subdivision and does not reflect absolute change in receptor levels. The three subdivisions
of IC have differential expression of GABAB receptors, with the ICd showing the highest level of
receptor subunit levels and the ICc showing the lowest level. A small absolute change in ICc can
translate to a large percent reduction whereas a similar or even greater absolute change in ICd
might not reach the same percent reduction. This can be seen in Table X where absolute change
and percentage change is listed for each subdivision. Therefore, a moderate change in ICd and
ICx can have more serious consequences on auditory processing than the relatively large change
in the ICc.
The hyperactivity reported by previously mentioned studies might be partially because of
the decrease in GABAB receptor levels seen in this study. However, the reported hyperactivity
can not entirely be attributed to a decrease in GABAB receptor levels. It must be noted that ICd
and ICx have an abundance of excitatory NMDA receptors compared to ICc (Ohishi et al.,
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1993). Therefore, it is possible that a slight decrease in inhibition i.e. a decrease in GABAB
receptor level, can tip the balance between excitation and inhibition in these subdivisions via
decreased regulation of the excitatory NMDA receptors. This decreased regulation leads to the
hyperactivity measured by the physiological and neuroimaging studies.
A higher reduction in ICc compared to ICd can affect auditory processing. ICc projects
mainly to the MGv which, like ICc, is part of the lemniscal pathway. MG is the last centre for
auditory processing before inputs are sent to the AC. A decrease in inhibition in the ICc could
mean that more excitatory inputs are sent to the MG which passes them on to the AC, thus
leading to improper auditory processing and tinnitus.
The role of ICd and ICx in auditory processing is not known. They have been shown to
contain neurons that habituate rapidly and respond to novel sounds. Habituation is a process by
which a neuron decreases its response to a stimulus over time, and is thought to involve
GABAergic inhibition. Failure to habituate can lead to audiogenic seizures (Chakravarty and
Faingold, 1996). A decrease in GABAB receptor subunit levels in these subdivisions can cause
the transmittance of noise that the neurons usually habituated to, thus producing hyperacusis. A
decrease in GABAB-mediated inhibition can also lead to audiogenic seizures where neurons fire
and transmit information to the higher structures even though no stimulus is present. This can
lead to perception of phantom sounds i.e. tinnitus. Therefore, a decrease in GABAB receptor
subunits and GABAB regulation in ICd and ICx can have more severe consequences on auditory
functioning. These two subdivisions might be more involved in the sensation of tinnitus than
ICc.
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5.4 Changes in GABABR1 and GABABR2 receptor levels in the MG
After IC, MG showed the greatest reduction in GABAB subunit levels. Not many studies
have been conducted on salicylate's effect on MG. The conducted studies show conflicting
results. Holt and colleagues (2010) found no change in activity in MG after chronic application
of SS. Wallhauser-Franke and colleagues (1997, 2003) found a slight increase in c-fos
expression, a marker for activity in neurons, in MGd but not in MGv after chronic SS
application. My results show a large decrease in GABAB receptor subunit levels in all the
subdivisions of the MG. The difference in findings might be due to the difference in
experimental procedures.
MGm showed the largest reduction, followed by MGv and MGd. MGv and MGd have a
higher level of GABAB receptors than MGm. Therefore, the percent reduction shown here might
be different than the absolute reduction as the different subdivisions have differential levels of
GABAB receptors. The three subdivisions also have different neural connections in the auditory
system. MGv and MGd project to the auditory cortex whereas MGm projects to non-auditory
areas. Thus a change in MGv and MGd might have more serious consequences on the function
of MG as a thalamic auditory relay structure than MGm.
MGv is considered a specific auditory relay centre (Gonzalez-Hernandez et al, 1991). It
receives ascending projections from ICc and descending projections from the AC (Malmierca
and Merchan, 2005). It is a major source of input to the AC (Winer and Schreiner, 2005). Thus
MGv is very important in auditory processing. A decrease in GABAB receptors in MGv can
affect the processing of ascending neural connections from the ICc. As it is the last relay
structure before inputs reach the AC, dysregulated neural inputs can be transmitted directly to the
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AC which processes all the incoming information. This leads to faulty neural processing and can
lead to hyperactivity in the AC, resulting in tinnitus and hyperacusis. Further research is needed
to be conducted on the MG to study the effects of SS on neural processing in the MGv, and how
this impacts neural processing in the primary auditory cortex that MGv projects to.
MGd receives ascending projections from ICd and ICx. It also sends descending
projections to the ICx, forming a feedback loop. MGd sends ascending projections to secondary
auditory cortices. A decrease in GABAB receptors in MGd not only leads to improper neural
processing of incoming information to the MG, but also in the ICx through faulty management of
the feedback loop. This can greatly impact the auditory information sent to the secondary
auditory cortices that MGd projects to, and can lead to tinnitus and hyperacusis. Further studies
are needed to conducted to study the role of MG in induction of tinnitus as this structure is
greatly affected by SS application in terms of GABAB receptor subunit levels.
5.5 Changes in GABABR1 and GABABR2 receptor levels in the AC
Previous physiological studies have reported an increase in activity of AC neurons after
systemic SS injection (Sun et al., 2009). This hyperactivity has been attributed to a decrease in
GABAergic inhibition (Sun et al., 2009; Lu et al., 2011). My IHC results indicate a reduction in
GABAB subunit immunoreactivity in the AC, and are in agreement with previous physiological
findings. It is believed that all cell types in the rat's primary auditory cortex are GABAergic
(Otterson and Strom-Mathisen, 1984; Winer and Larue, 1989; Winer, 1992). Thus GABAergic
inhibition plays a major role in neural processing in the AC, and even a small decrease in
GABAB receptor levels might lead to significant increases in neural activity. Since AC is
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involved in auditory perception, the increase in neural activity can manifest as an auditory
disorder e.g. tinnitus.
There were no significant differences in GABAB receptor subunit levels amongst the
three subdivisions of the AC. However, the different layers of the AC showed differential affect
of the drug. The deep layers i.e. layers IV-VI of the AC showed a greater qualitative reduction in
GABAB receptor levels than the superficial layers. The deep layers of AC receive ascending
inputs from IC and MG. These layers also send descending projections to those structures,
forming feedback loops to regulate neural processing (Winer and Larue, 1987; Roger and
Arnault, 1989; Arnault and Roger, 1990). A decrease in the levels of GABAB receptor not only
causes faulty processing of incoming information, but also of descending inputs. The improper
regulation through the descending inputs can cause inaccurate neural processing in the lower
structures which in turn send inaccurate auditory information to the AC, thus forming a positive
feedback loop. This can lead to information which is usually filtered being sent to the AC. These
layers receive and process the gain of the auditory system due to changes in lower auditory, and
in turn, display hyperactivity which leads to the sensation of tinnitus. Therefore, the deep layers
of AC might play a greater role in tinnitus sensation than the superficial layers.
5.6 Cellular distributions of reduction in the level of the GABABR1 and GABABR2
subunits:
In all the auditory structures analyzed, the reduction in the level of the GABABR1 and
GABABR2 subunits was greater in cell bodies than in the neuropil,. The number of labeled cell
bodies and the OD of labeled cell bodies decreased after SS treatment. Cell bodies contain the
machinery to make proteins. Both the GABABR1 and GABABR2 subunit are made in the ER
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(Pin et al., 2004; Restituito et al., 2005). The subunits can join together to traffic to the cell
membrane to form a functional receptor. In photomicrographic images, the cell membrane can be
visualized in either cell body areas or the neuropil, which contains the axons and dendrites. A
reduction in cell body receptor subunit levels could reflect a reduction in the level of functional
GABAB receptors or a decrease in the levels of individual subunits available to make the
functional receptor. Recent studies have shown that SS can modify mRNA levels of various
proteins in the auditory structure 2-3 hours after systemic application of the drug (Panford-Walsh
et al., 2008; Zou and Shang, 2012; Hu et al., 2014). The time frame in which these changes
happen coincides with that in which levels of GABAB receptor subunits were reduced.
The levels of GABAB receptor subunits in the neuropil were reduced in all the auditory
structures after application of SS. The subunits in the neuropil are most likely associated with
functional receptors as neuropil contains the axons and dendrites of neuron cell bodies. The
decrease in neuropil labeling is probably due to a reduction in receptor subunits available for
making functional receptors and not due to the effect of SS on receptor stability. To date, no
studies have been conducted to study the effect of SS on receptor stability. Studies looking at the
early or immediate effect have shown that SS can inhibit GABA receptors and GABAergic
inhibition, indicating that SS can interact with the GABA receptors. The possibility that SS
might cause a change in receptor stability by destabilizing the receptor and might cause a
reduction in receptor levels in the neuropil cannot be ruled out.
The decrease in subunit levels may or may not be related to receptor turnover. GABAB
receptors constantly traffic in and out of the cell membrane. Studies monitoring GABAB receptor
trafficking have found that the receptors are dynamically regulated, with an internalization rate
of 40±4 mins. The rate of insertion is faster at 7.8±2 mins (Wilkins et al., 2008). The receptors
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are constantly replenished to maintain proper neural function. SS might affect the cellular
mechanisms involved in regulating receptor turnover, and may either enhance the internalization
of receptors or prevent the reinsertion of receptors , thereby reducing the receptors expressed on
the cell membrane.
The rate of internalization of GABAB receptors is affected by agonist and antagonist
binding. Binding of agonists increases the rate of internalization whereas antagonist binding
decreases the rate of internalization (Wilkins et al., 2008). Physiological studies on the direct
effect of SS on neural activity report that SS decreases the inhibitory post-synaptic potentials
caused by GABAB receptor activation, indicating that SS has an antagonistic effect on the
GABAB receptors (Lu et al., 2011). Thus the reduction seen in this study cannot be attributed to
receptor internalization since the antagonistic action of SS would decrease the rate of
internalization and cause more receptors to be expressed on the cell membrane. However, the
possibility that SS causes changes in receptor stability cannot be ruled out. Further research is
needed to be conducted to address the effect of SS on receptor stability.
7 Conclusions and future directions:
Intraperitoneal injection of SS causes a reduction in the level of GABABR1 and
GABABR2 subunits in all the major auditory structures. This reduction is different for different
structures. The IC and MG are affected the most by the effect of SS treatment. The drug had a
greater affect on the levels of subunits in the cell bodies than in the neuropil..
My research provides a basis for future tinnitus research to focus on GABAB receptors. I
studied the effect of SS, a tinnitus inducer, on the level of GABAB receptors in the auditory
structures. However, tinnitus is also induced by exposure to loud noises. In fact, loud noise is the
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cause of approximately 23% of reported tinnitus cases (Tinnitus archive, Oregon Health and
Science University). Future studies can examine the possible involvement of GABAB receptors
in noise-induced tinnitus by pairing behavioural studies with immunohistochemical studies.
Researchers can study changes in GABAB receptor levels in each auditory structure after
exposure to loud noise to determine if the receptor levels are affected in a manner similar to that
seen after treatment with SS.
Physiological studies monitoring the activity of GABAB receptors during tinnitus can be
conducted to decipher the functional role of these receptors in tinnitus. Since my results showed
a decrease in GABAB receptor levels in all auditory structures, the activity of GABAB receptors
in each auditory structure can be studied to determine the relative contribution of each structure
to the tinnitus sensation. Pharmacological manipulation using agonists and antagonists can be
paired with behavioural studies. The receptors can be blocked using antagonists or activated
using agonists and the strength of tinnitus sensation can be measured using behavioural
paradigms to fully decipher the involvement of these receptors in tinnitus sensation.
Future research can study the effect of SS on cellular mechanisms responsible for
synthesizing GABAB receptor subunits. The higher reduction in the cell bodies indicates that SS
may be affecting cellular mechanisms. Future studies can monitor effect of SS on transcriptional
and translational machinery to determine the cellular targets of SS as the drug affects more than
just GABAB receptors. The proteins involved in transcription or translation can be knocked out
in a systematic manner and change in receptor levels monitored after SS application to determine
the involvement of the protein in the effect of SS application. The transcription and translation of
GABAB receptor subunits can also be monitored to see which stage is more affected by SS. The
two subunits are needed to make a functional receptor, and in the absence of one, the other
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subunit is degraded and recycled. Further research is needed to determine if SS affects one
subunit's production or stability more than the other, resulting in the downregulation of the other
subunit. The effect of SS on receptor stability can also be studied. Florescent tags can be used to
tag the GABAB receptors and monitor their stability during the 3 hour time frame of SS's effect
to determine if SS can destabilize the functional receptor or a subunit and cause changes in
receptor levels.
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TABLES
TABLE 2: Summary results regarding the effect of SS on the GABABR1 subunit in four auditory
structures
% change in GABABR1 labeling
CN

IC

MG

AC

OVERALL

16.1

31.2

34.0

11.1

CELL BODY

70.9

82.7

81.6

47.1

NEUROPIL

15.4

30.4

32.3

10.6
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TABLE 3: Summary results regarding the effect of SS on the GABABR1 subunit in the
subdivisions of four auditory structures

GABABR1 levels
overall

CN

IC

MG

AC

Cell body

neuropil

OD

OD

%

Total

Total

%

OD

OD

%

SAL

SS

reduction

# SAL

# SS

reduction

SAL

SS

reduction

DCN

90.01

100.1

16.1

2395

630

73.7

90.8

100.3

15.3

PVCN

92.6

111.3

28.4

2084

672

67.8

94.3

111.8

27.4

AVCN

101.5

114.1

34.6

6210

1806

70.9

103.2

114.3

33.3

ICd

87.0

103.5

31.2

11435

3376

70.5

88.2

104.0

30.4

ICx

97.9

113.4

36.1

18553

3522

81.0

99.4

113.7

34.5

ICc

96.8

117.5

47.0

13202

564

95.7

98.0

117.6

45.7

MGd

102.7

118.5

35.8

1688

456

73.0

104.6

119.1

34.3

MGv

103.7

121.4

41.7

3674

585

84.1

105.4

121.8

40.1

MGm

107.1

125.2

47.0

634

61

90.3

108.4

125.4

45.5

AU1

85.4

94.9

11.1

13446

7310

45.6

86.9

95.8

10.6

AUD

84.5

95.8

13.5

5291

2722

48.6

86.1

96.7

13.3

AUV

86.9

98.2

14.5

4443

2227

49.9

88.5

99.4

14.2
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TABLE 4: Summary results regarding the effect of SS on GABABR2 subunit in four major
auditory structures.
% change in GABABR2 labeling
CN

IC

MG

AC

OVERALL

11.0

24.0

23.3

12.3

CELL BODY

42.2

72.3

70.0

33.7

NEUROPIL

10.4

23.1

21.9

12.2
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TABLE 5: Summary results regarding the effect of SS on the GABABR1 subunit in the
subdivisions of four auditory structures.
GABABR2 levels
overall

CN

IC

MG

AC

Cell body

neuropil

OD

OD

%

Total

Total

%

OD

OD

%

SAL

SS

reduction

# SAL

# SS

reduction

SAL

SS

reduction

DCN

87.3

93.5

11.4

2444

1819

25.6

88.8

94.4

10.4

PVCN

89.5

99.5

21.9

1845

868

53.0

91.8

101.2

21.9

AVCN

99.9

103.4

7.5

1502

661

56.0

101.9

105.3

7.8

ICd

106.7

116.4

24.0

8491

3246

61.8

107.6

116.8

23.1

ICx

117.0

125.3

27.5

12718

3473

72.7

118.0

125.6

25.7

ICc

117.2

125.7

27.9

8234

1436

82.6

118.2

126.3

27.6

MGd

106.9

115.8

22.5

918

291

68.3

108.2

116.1

20.7

MGv

109.2

117.2

22.1

1729

539

68.8

109.8

117.4

21.3

MGm

110.3

121.1

31.2

366

73

20.0

111.8

121.3

28.8

AU1

100.8

106.9

12.3

11349

7699

32.1

101.8

107.7

12.2

AUD

101.2

107.6

13.0

4902

3258

33.5

102

108.3

12.7

AUV

103.3

109.7

13.6

3242

1975

39.1

104

110.2

13.4
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TABLE 6: Densitometry values of GABABR1α and GABABR1β subunits.
CB
SAL

CN
SS

SAL

GABABR1α 10512

9681

8611

GABABR1β

7154

6017

6634

IC
SS

SAL

MG

AC

SS

SAL

6940 12306

8218

13576

13355 12363 10722

5116

5144

8935

7726

7366
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SS

SAL

10506

SS

8670
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APPENDICES
Solutions used in Immunohistochemistry procedures:
0.5M Sodium Phosphate Dibasic
For 1L
70.98g sodium phosphate dibasic powder (NaH2PO4•H2O)
1L of dH2O
0.5M Sodium Phosphate Monobasic
Fo 1L
68.99g anhydrous sodium phosphate monobasic (NaH2PO4)
1L dH2O
0.4M Sodium Phosphate Buffer (PB) (pH=7.2)
For 1L
600ml 0.5M sodium phosphate dibasic solution
200ml 0.5M sodium phosphate monobasic solution
200ml dH2O
0.1M Sodium Phosphate Buffer (PB) (pH=7.2)
For 1L
250ml 0.4M PB
750ml dH2O
0.1M Phosphate Buffer Saline (PBS) (pH=7.2)
For 1L
250ml 0.4M PB
750ml dH2O
4% Paraformaldehyde (PFA) in 0.1M PB (pH = 7.2)
For 1L
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40g PFA powder
1L 0.1M PB
Dissolve PFA powder into PB by heating on a stir plate at low heat settings
Adjust pH with either HCl or NaOH
Cryoprotectant solution
For 100ml
30g sucrose
100ml PB
0.05% Triton in 0.1M PBS (TPBS)
For 1L
0.05ml Triton X-100
1L 0.1M PBS
3,3' diaminobenzidine tetrahydrochloride (DAB)-nickel solution
For 20ml solution
5ml 0.4M PB
200µl 0.4% NH4Cl in 0.1M PB solution
200µl Glucose
13.6ml dH2O
200µl of 50mg/ml DAB (D5637, Sigma-Aldrich, Oakville, ON, Canada) in 0.1M PB
0.8ml 1% Nickel suplhate in dH2O
20µl of Glucose oxidase (G3660, Sigma-Aldrich)
Solutions used in Western blotting procedures:
Homogenization buffer:
For 10ml solution:
25µl 1M Tris-HCL (pH = 8.0)
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225µl 1M NaCl
20µl 0.5mM EDTA
100µl Triton x-100
Protease inhibitors:
0.5µl/ml aprotinin
10µl/ml PMSF (phenylmethanesulfonyl fluoride)
1µl/m/ leupeptin
1µg/ml pepstatin A
Electrophoresis Sample Buffer (4X):
For 100ml
40ml 87% Glycerol
10ml 2-β-mercaptoethanol
40ml 10% SDS (sodium dodecyl sulphate)
100ml 0.5M Tris-HCL
4ml 1% Bromophenol blue
6ml dH2O
Lower Gel Buffer (pH = 6.8):
For 1L
182g Tris base
4g SDS
Bring volume up to 1L with dH2O
7.5% Lower gel:
For approximately 30ml solution
16.875ml dH2O
7.5ml lower gel buffer
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5.625ml acrylamide
112.5µl 10% APS (ammonium persulphate)
33.75µl TEMED (N,N,N,N'-tetramethylenediamine)
Upper Gel Buffer (pH = 6.8):
For 200ml
12.1g Tris base
0.8g SDS
Bring volume up to 200ml with dH2O
Stacking Gel:
For approximately 10ml solution
6.4ml dH2O
2.5ml upper gel buffer
1.125ml acrylamide
30µl 10% APS
20µl TEMED
5X Running Buffer (pH = 8.2)
For approximately 1L
15.1g Tris base
94g Glycine
25ml 10% SDS
Transfer Buffer (pH = 9.2)
TBS-Tween (TBST) Buffer:
For 1L
5ml 10% Tween
995ml TBS buffer
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